GSE	geo_accession	xpType	RefDye	Note	Group	Ignore	XP	Batch	isCTRL	Node	NodeFunction	BSM	BSMDCD	BSMDCD2	BioSampName	title	source_name_ch1	source_name_ch2	characteristics_ch1.1	characteristics_ch1.2	characteristics_ch1.3	characteristics_ch1.4	characteristics_ch1.5	characteristics_ch1.6	characteristics_ch1.7	characteristics_ch2.1	characteristics_ch2.2	characteristics_ch2.3	characteristics_ch2.4	characteristics_ch2.5	characteristics_ch1	characteristics_ch2	platform_id	description.9	description	description.1	description.2	description.3	description.4	description.5	description.6	description.7	description.8
GSE4445	GSM99893	2CDirectDyeSwap	Cy5	Ref=WT	A	0	1		0	TLR7	OE				B lymphocytes	TLR7 gene duplication accelerates autoimmunity and promotes nucleolar-specific B cells	"Follicular B cells from spleen, fresh Isolation"	"Follicular B cells from spleen, fresh Isolation"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"C57BL/6.Yaa, male, 2 months, follicular B cells, fresh Isolation"	"C57BL/6, male, 2 months, follicular B cells, fresh Isolation"	GPL1057	Override other Chan A & B criteria and Include if Chan A Signal >= 5000 OR Chan B Signal >= 5000.	Criteria for data extraction.	Signal calculation: Median Intensity minus Median Background	Any Features designated Control was excluded.	Normalization method: 50th Percentile (Median) using all spot filtered Genes	Spot Filter Options:	Include Spots not flagged BAD or Not Found	AND Target diameter >= 50 um AND Target diameter <= 300 um	AND Both Chan A and Chan B Signal/Background Ratios >= 2.000	AND Both Chan A and Chan B Percentage Target Pixels 1 SD above Background >= 25%
GSE4445	GSM100003	2CDirectDyeSwap	Cy3	Ref=WT	A	0	1		0	TLR7	OE				B lymphocytes	TLR7 gene duplication accelerates autoimmunity and promotes nucleolar-specific B cells (sample2)	"Follicular B cells from spleen, fresh Isolation"	"Follicular B cells from spleen, fresh Isolation"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"C57BL/6, male, 2 months, follicular B cells, fresh Isolation"	"C57BL/6.Yaa, male, 2, months, follicular B cells, fresh Isolation"	GPL1057	Override other Chan A & B criteria and Include if Chan A Signal >= 5000 OR Chan B Signal >= 5000.	Criteria for data extraction.	Signal calculation: Median Intensity minus Median Background	Any Features designated Control was excluded.	Normalization method: 50th Percentile (Median) using all spot filtered Genes	Spot Filter Options:	Include Spots not flagged BAD or Not Found	AND Target diameter >= 50 um AND Target diameter <= 300 um	AND Both Chan A and Chan B Signal/Background Ratios >= 2.000	AND Both Chan A and Chan B Percentage Target Pixels 1 SD above Background >= 25%
GSE4445	GSM100005	2CDirectDyeSwap	Cy3	Ref=WT	A	0	1		0	TLR7	OE				B lymphocytes	TLR7 gene duplication accelerates autoimmunity and promotes nucleolar-specific B cells (sample3)	"Follicular B cells from spleen, fresh Isolation"	"Follicular B cells from spleen, fresh Isolation"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"C57BL/6, male, 2 months, follicular B cells, fresh Isolation"	"C57BL/6.Yaa, male, 2 months, follicular B cells, fresh Isolation"	GPL1057	Override other Chan A & B criteria and Include if Chan A Signal >= 5000 OR Chan B Signal >= 5000.	Criteria for data extraction.	Signal calculation: Median Intensity minus Median Background	Any Features designated Control was excluded.	Normalization method: 50th Percentile (Median) using all spot filtered Genes	Spot Filter Options:	Include Spots not flagged BAD or Not Found	AND Target diameter >= 50 um AND Target diameter <= 300 um	AND Both Chan A and Chan B Signal/Background Ratios >= 2.000	AND Both Chan A and Chan B Percentage Target Pixels 1 SD above Background >= 25%
GSE4445	GSM100006	2CDirectDyeSwap	Cy3	Ref=WT	A	0	1		0	TLR7	OE				B lymphocytes	TLR7 gene duplication accelerates autoimmunity and promotes nucleolar-specific B cells (sample4)	"Follicular B cells from spleen, fresh Isolation"	"Follicular B cells from spleen, fresh Isolation"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"C57BL/6, male, 2 months, follicular B cells, fresh Isolation"	"C57BL/6.Yaa, male, 2 months, follicular B cells, fresh Isolation"	GPL1057	Override other Chan A & B criteria and Include if Chan A Signal >= 5000 OR Chan B Signal >= 5000.	Criteria for data extraction.	Signal calculation: Median Intensity minus Median Background	Any Features designated Control was excluded.	Normalization method: 50th Percentile (Median) using all spot filtered Genes	Spot Filter Options:	Include Spots not flagged BAD or Not Found	AND Target diameter >= 50 um AND Target diameter <= 300 um	AND Both Chan A and Chan B Signal/Background Ratios >= 2.000	AND Both Chan A and Chan B Percentage Target Pixels 1 SD above Background >= 25%
						NA			NA																																		
GSE22124	GSM550277	1C|TS			a	0	1		1			(Veh)	0h		RAW macrophages	RAW_media_t0_rep1	RAW cells in DMEM	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550278	1C|TS			a	0	1		1			(Veh)	0h		RAW macrophages	RAW_media_t0_rep2	RAW cells in DMEM	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550279	1C|TS			b	0	1		1			(Veh)	1h		RAW macrophages	RAW_media_t1	RAW cells in DMEM	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550280	1C|TS			A	0	1		0			R848	1h	0.1 uM	RAW macrophages	RAW_R848_t1	RAW cells in DMEM were stimulatate with R848 for 1h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550281	1C|TS			B	0	1		0			R848;apilimod	1h	0.1 uM;1 uM	RAW macrophages	RAW_R848+apilimod_t1	RAW cells in DMEM were stimulatate with R848 in the presence of apilimod for 1h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550282	1C|TS		API09=inactive control=Veh	A	0	1		0			R848	1h	0.1 uM	RAW macrophages	RAW_R848+API09_t1	RAW cells in DMEM were stimulatate with R848 in the presence of API09 for 1h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550283	1C|TS			d	0	1		1			(Veh)	3h		RAW macrophages	RAW_media_t3	RAW cells in DMEM	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550284	1C|TS			E	0	1		0			R848	3h	0.1 uM	RAW macrophages	RAW_R848_t3	RAW cells in DMEM were stimulatate with R848 for 3h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550285	1C|TS			F	0	1		0			R848;apilimod	3h	0.1 uM;1 uM	RAW macrophages	RAW_R848+apilimod_t3	RAW cells in DMEM were stimulatate with R848 in the presence of apilimod for 3h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550286	1C|TS		API09=inactive control=Veh	E	0	1		0			R848	3h	0.1 uM	RAW macrophages	RAW_R848+API09_t3	RAW cells in DMEM were stimulatate with R848 in the presence of API09 for 3h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550287	1C|TS			e	0	1		1			(Veh)	7h		RAW macrophages	RAW_media_t7	RAW cells in DMEM	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550288	1C|TS			G	0	1		0			R848	7h	0.1 uM	RAW macrophages	RAW_R848_t7	RAW cells in DMEM were stimulatate with R848 for 7h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550289	1C|TS			H	0	1		0			R848;apilimod	7h	0.1 uM;1 uM	RAW macrophages	RAW_R848+apilimod_t7	RAW cells in DMEM were stimulatate with R848 in the presence of apilimod for 7h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550290	1C|TS		API09=inactive control=Veh	G	0	1		0			R848	7h	0.1 uM	RAW macrophages	RAW_R848+API09_t7	RAW cells in DMEM were stimulatate with R848 in the presence of API09 for 7h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550291	1C|TS			c	0	1		1			(Veh)	22h		RAW macrophages	RAW_media_t22	RAW cells in DMEM	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550292	1C|TS			C	0	1		0			R848	22h	0.1 uM	RAW macrophages	RAW_R848_t22	RAW cells in DMEM were stimulatate with R848 for 22h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550293	1C|TS			D	0	1		0			R848;apilimod	22h	0.1 uM;1 uM	RAW macrophages	RAW_R848+apilimod_t22	RAW cells in DMEM were stimulatate with R848 in the presence of apilimod for 22h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE22124	GSM550294	1C|TS		API09=inactive control	C	0	1		0			R848	22h	0.1 uM	RAW macrophages	RAW_R848+API09_t22	RAW cells in DMEM were stimulatate with R848 in the presence of API09 for 22h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: macrophage cell line	NA	GPL1261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE64480	GSM1572093	1C			a	0	1		1			(Veh)	12h		monocytes	Donor 1 untreated	monocytes	NA	individual: deidentified donor 1	cell type: monocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	treatment: untreated	NA	GPL570	NA	UT_01	NA	NA	NA	NA	NA	NA	NA	NA
GSE64480	GSM1572094	1C			A	0	1		0			3M-055	12h	1 uM	monocytes	Donor 1 TLR7 agonist	monocytes	NA	individual: deidentified donor 1	cell type: monocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	treatment: TLR7 agonist	NA	GPL570	NA	TLR7_01	NA	NA	NA	NA	NA	NA	NA	NA
GSE64480	GSM1572095	1C			B	0	1		0			VTX-2337	12h	1 uM	monocytes	Donor 1 TLR8 agonist	monocytes	NA	individual: deidentified donor 1	cell type: monocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	treatment: TLR8 agonist	NA	GPL570	NA	TLR8_01	NA	NA	NA	NA	NA	NA	NA	NA
GSE64480	GSM1572096	1C			a	0	1		1			(Veh)	12h		monocytes	Donor 2 untreated	monocytes	NA	individual: deidentified donor 2	cell type: monocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	treatment: untreated	NA	GPL570	NA	UT_02	NA	NA	NA	NA	NA	NA	NA	NA
GSE64480	GSM1572097	1C			A	0	1		0			3M-055	12h	1 uM	monocytes	Donor 2 TLR7 agonist	monocytes	NA	individual: deidentified donor 2	cell type: monocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	treatment: TLR7 agonist	NA	GPL570	NA	TLR7_02	NA	NA	NA	NA	NA	NA	NA	NA
GSE64480	GSM1572098	1C			B	0	1		0			VTX-2337	12h	1 uM	monocytes	Donor 2 TLR8 agonist	monocytes	NA	individual: deidentified donor 2	cell type: monocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	treatment: TLR8 agonist	NA	GPL570	NA	TLR8_02	NA	NA	NA	NA	NA	NA	NA	NA
GSE64480	GSM1572099	1C			a	0	1		1			(Veh)	12h		monocytes	Donor 3 untreated	monocytes	NA	individual: deidentified donor 3	cell type: monocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	treatment: untreated	NA	GPL570	NA	UT_03	NA	NA	NA	NA	NA	NA	NA	NA
GSE64480	GSM1572100	1C			A	0	1		0			3M-055	12h	1 uM	monocytes	Donor 3 TLR7 agonist	monocytes	NA	individual: deidentified donor 3	cell type: monocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	treatment: TLR7 agonist	NA	GPL570	NA	TLR7_03	NA	NA	NA	NA	NA	NA	NA	NA
GSE64480	GSM1572101	1C			B	0	1		0			VTX-2337	12h	1 uM	monocytes	Donor 3 TLR8 agonist	monocytes	NA	individual: deidentified donor 3	cell type: monocytes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	treatment: TLR8 agonist	NA	GPL570	NA	TLR8_03	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE67057	GSM1637575	1C			a	0	1	neonate	1			(Veh)			dendritic cells	cDC_Neonate_Unstim_0h_subj1	Cord blood	NA	age group: Neonate	individual: 1	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1723260056_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637576	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	cDC_Neonate_3M003_1h_subj1	Cord blood	NA	age group: Neonate	individual: 1	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1723260056_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637577	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	cDC_Neonate_3M003_6h_subj1	Cord blood	NA	age group: Neonate	individual: 1	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1723260056_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637578	1C			a	0	1	neonate	1			(Veh)			dendritic cells	cDC_Neonate_Unstim_0h_subj2	Cord blood	NA	age group: Neonate	individual: 2	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089057_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637579	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	cDC_Neonate_3M003_1h_subj2	Cord blood	NA	age group: Neonate	individual: 2	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089057_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637580	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	cDC_Neonate_3M003_6h_subj2	Cord blood	NA	age group: Neonate	individual: 2	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089057_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637581	1C			a	0	1	neonate	1			(Veh)			dendritic cells	cDC_Neonate_Unstim_0h_subj3	Cord blood	NA	age group: Neonate	individual: 3	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089072_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637582	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	cDC_Neonate_3M003_1h_subj3	Cord blood	NA	age group: Neonate	individual: 3	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089072_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637583	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	cDC_Neonate_3M003_6h_subj3	Cord blood	NA	age group: Neonate	individual: 3	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089072_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637584	1C			a	0	1	adult	1			(Veh)			dendritic cells	cDC_Adult_Unstim_0h_subj1	Peripheral blood	NA	age group: Adult	individual: 1	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089072_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637585	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	cDC_Adult_3M003_1h_subj1	Peripheral blood	NA	age group: Adult	individual: 1	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089072_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637586	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	cDC_Adult_3M003_6h_subj1	Peripheral blood	NA	age group: Adult	individual: 1	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089072_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637587	1C			a	0	1	adult	1			(Veh)			dendritic cells	cDC_Adult_Unstim_0h_subj2	Peripheral blood	NA	age group: Adult	individual: 2	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1848089056_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637588	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	cDC_Adult_3M003_1h_subj2	Peripheral blood	NA	age group: Adult	individual: 2	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1848089056_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637589	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	cDC_Adult_3M003_6h_subj2	Peripheral blood	NA	age group: Adult	individual: 2	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1848089056_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637590	1C			a	0	1	neonate	1			(Veh)			dendritic cells	cDC_Neonate_Unstim_0h_subj4	Cord blood	NA	age group: Neonate	individual: 4	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1848089056_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637591	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	cDC_Neonate_3M003_1h_subj4	Cord blood	NA	age group: Neonate	individual: 4	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1848089056_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637592	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	cDC_Neonate_3M003_6h_subj4	Cord blood	NA	age group: Neonate	individual: 4	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1848089056_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637593	1C			a	0	1	neonate	1			(Veh)			dendritic cells	cDC_Neonate_Unstim_0h_subj5	Cord blood	NA	age group: Neonate	individual: 5	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857160_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637594	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	cDC_Neonate_3M003_1h_subj5	Cord blood	NA	age group: Neonate	individual: 5	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857160_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637595	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	cDC_Neonate_3M003_6h_subj5	Cord blood	NA	age group: Neonate	individual: 5	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857160_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637596	1C			a	0	1	neonate	1			(Veh)			dendritic cells	cDC_Neonate_Unstim_0h_subj6	Cord blood	NA	age group: Neonate	individual: 6	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857160_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637597	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	cDC_Neonate_3M003_1h_subj6	Cord blood	NA	age group: Neonate	individual: 6	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857160_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637598	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	cDC_Neonate_3M003_6h_subj6	Cord blood	NA	age group: Neonate	individual: 6	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857160_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637599	1C			a	0	1	adult	1			(Veh)			dendritic cells	cDC_Adult_Unstim_0h_subj3	Peripheral blood	NA	age group: Adult	individual: 3	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1888857183_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637600	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	cDC_Adult_3M003_1h_subj3	Peripheral blood	NA	age group: Adult	individual: 3	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1888857183_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637601	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	cDC_Adult_3M003_6h_subj3	Peripheral blood	NA	age group: Adult	individual: 3	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1888857183_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637602	1C			a	0	1	adult	1			(Veh)			dendritic cells	cDC_Adult_Unstim_0h_subj4	Peripheral blood	NA	age group: Adult	individual: 4	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857183_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637603	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	cDC_Adult_3M003_1h_subj4	Peripheral blood	NA	age group: Adult	individual: 4	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857183_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637604	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	cDC_Adult_3M003_6h_subj4	Peripheral blood	NA	age group: Adult	individual: 4	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857183_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637605	1C			a	0	1	adult	1			(Veh)			dendritic cells	cDC_Adult_Unstim_0h_subj5	Peripheral blood	NA	age group: Adult	individual: 5	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1888857205_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637606	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	cDC_Adult_3M003_1h_subj5	Peripheral blood	NA	age group: Adult	individual: 5	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1888857205_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637607	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	cDC_Adult_3M003_6h_subj5	Peripheral blood	NA	age group: Adult	individual: 5	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1888857205_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637608	1C			a	0	1	adult	1			(Veh)			dendritic cells	cDC_Adult_Unstim_0h_subj6	Peripheral blood	NA	age group: Adult	individual: 6	cell type: cDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857205_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637609	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	cDC_Adult_3M003_1h_subj6	Peripheral blood	NA	age group: Adult	individual: 6	cell type: cDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857205_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637610	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	cDC_Adult_3M003_6h_subj6	Peripheral blood	NA	age group: Adult	individual: 6	cell type: cDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1888857205_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637611	1C			a	0	1	adult	1			(Veh)			dendritic cells	pDC_Adult_Unstim_0h_subj1	Peripheral blood	NA	age group: Adult	individual: 1	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460254_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637612	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	pDC_Adult_3M003_1h_subj1	Peripheral blood	NA	age group: Adult	individual: 1	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460254_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637613	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	pDC_Adult_3M003_6h_subj1	Peripheral blood	NA	age group: Adult	individual: 1	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460254_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637614	1C			a	0	1	neonate	1			(Veh)			dendritic cells	pDC_Neonate_Unstim_0h_subj1	Cord blood	NA	age group: Neonate	individual: 1	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460254_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637615	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	pDC_Neonate_3M003_1h_subj1	Cord blood	NA	age group: Neonate	individual: 1	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460254_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637616	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	pDC_Neonate_3M003_6h_subj1	Cord blood	NA	age group: Neonate	individual: 1	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460254_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637617	1C			a	0	1	adult	1			(Veh)			dendritic cells	pDC_Adult_Unstim_0h_subj2	Peripheral blood	NA	age group: Adult	individual: 2	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1723260020_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637618	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	pDC_Adult_3M003_1h_subj2	Peripheral blood	NA	age group: Adult	individual: 2	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1723260020_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637619	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	pDC_Adult_3M003_6h_subj2	Peripheral blood	NA	age group: Adult	individual: 2	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1723260020_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637620	1C			a	0	1	adult	1			(Veh)			dendritic cells	pDC_Adult_Unstim_0h_subj3	Peripheral blood	NA	age group: Adult	individual: 3	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260020_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637621	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	pDC_Adult_3M003_1h_subj3	Peripheral blood	NA	age group: Adult	individual: 3	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260020_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637622	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	pDC_Adult_3M003_6h_subj3	Peripheral blood	NA	age group: Adult	individual: 3	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260020_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637623	1C			a	0	1	neonate	1			(Veh)			dendritic cells	pDC_Neonate_Unstim_0h_subj2	Cord blood	NA	age group: Neonate	individual: 2	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460247_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637624	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	pDC_Neonate_3M003_1h_subj2	Cord blood	NA	age group: Neonate	individual: 2	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460247_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637625	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	pDC_Neonate_3M003_6h_subj2	Cord blood	NA	age group: Neonate	individual: 2	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460247_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637626	1C			a	0	1	neonate	1			(Veh)			dendritic cells	pDC_Neonate_Unstim_0h_subj3	Cord blood	NA	age group: Neonate	individual: 3	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460247_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637627	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	pDC_Neonate_3M003_1h_subj3	Cord blood	NA	age group: Neonate	individual: 3	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460247_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637628	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	pDC_Neonate_3M003_6h_subj3	Cord blood	NA	age group: Neonate	individual: 3	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1714460247_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637629	1C			a	0	1	adult	1			(Veh)			dendritic cells	pDC_Adult_Unstim_0h_subj4	Peripheral blood	NA	age group: Adult	individual: 4	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260021_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637630	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	pDC_Adult_3M003_1h_subj4	Peripheral blood	NA	age group: Adult	individual: 4	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260021_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637631	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	pDC_Adult_3M003_6h_subj4	Peripheral blood	NA	age group: Adult	individual: 4	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260021_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637632	1C			a	0	1	adult	1			(Veh)			dendritic cells	pDC_Adult_Unstim_0h_subj5	Peripheral blood	NA	age group: Adult	individual: 5	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260021_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637633	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	pDC_Adult_3M003_1h_subj5	Peripheral blood	NA	age group: Adult	individual: 5	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260021_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637634	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	pDC_Adult_3M003_6h_subj5	Peripheral blood	NA	age group: Adult	individual: 5	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260021_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637635	1C			a	0	1	neonate	1			(Veh)			dendritic cells	pDC_Neonate_Unstim_0h_subj4	Cord blood	NA	age group: Neonate	individual: 4	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260009_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637636	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	pDC_Neonate_3M003_1h_subj4	Cord blood	NA	age group: Neonate	individual: 4	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260009_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637637	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	pDC_Neonate_3M003_6h_subj4	Cord blood	NA	age group: Neonate	individual: 4	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260009_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637638	1C			a	0	1	neonate	1			(Veh)			dendritic cells	pDC_Neonate_Unstim_0h_subj5	Cord blood	NA	age group: Neonate	individual: 5	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260009_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637639	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	pDC_Neonate_3M003_1h_subj5	Cord blood	NA	age group: Neonate	individual: 5	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260009_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637640	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	pDC_Neonate_3M003_6h_subj5	Cord blood	NA	age group: Neonate	individual: 5	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260009_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637641	1C			a	0	1	neonate	1			(Veh)			dendritic cells	pDC_Neonate_Unstim_0h_subj6	Cord blood	NA	age group: Neonate	individual: 6	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260056_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637642	1C			A	0	1	neonate	0			3M-003	1h	5 uM	dendritic cells	pDC_Neonate_3M003_1h_subj6	Cord blood	NA	age group: Neonate	individual: 6	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260056_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637643	1C			B	0	1	neonate	0			3M-003	6h	5 uM	dendritic cells	pDC_Neonate_3M003_6h_subj6	Cord blood	NA	age group: Neonate	individual: 6	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Male	NA	GPL6102	NA	Sample name: 1723260056_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637644	1C			a	0	1	adult	1			(Veh)			dendritic cells	pDC_Adult_Unstim_0h_subj6	Peripheral blood	NA	age group: Adult	individual: 6	cell type: pDC	agent: control	time: 0h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089057_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637645	1C			A	0	1	adult	0			3M-003	1h	5 uM	dendritic cells	pDC_Adult_3M003_1h_subj6	Peripheral blood	NA	age group: Adult	individual: 6	cell type: pDC	agent: 3M003	time: 1h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089057_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE67057	GSM1637646	1C			B	0	1	adult	0			3M-003	6h	5 uM	dendritic cells	pDC_Adult_3M003_6h_subj6	Peripheral blood	NA	age group: Adult	individual: 6	cell type: pDC	agent: 3M003	time: 6h	NA	NA	NA	NA	NA	NA	NA	gender: Female	NA	GPL6102	NA	Sample name: 1848089057_C	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE41825	GSM1025019	1C			C	0	1		0			ODN2216	3h	1 uM	dendritic cells	pDC_ODN2216_3hrs_donor_1 (1_1_3)	"pDC from donor 1, ODN 2216, 3 hrs"	NA	treatment: ODN 2216	timepoint: 3 hrs	subject: 1	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	1_1_3_2216	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025020	1C			A	0	1		0			gardiquimod	3h	5 uM	dendritic cells	pDC_Gard_3hrs_donor_1 (3_1_3)	"pDC from donor 1, gardiquimod, 3 hrs"	NA	treatment: gardiquimod	timepoint: 3 hrs	subject: 1	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	3_1_3_Gard	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025021	1C			a	0	1		1			(Veh)	3h		dendritic cells	pDC_Untreated_3hrs_donor_1 (5_1_3)	"pDC from donor 1, untreated, 3 hrs"	NA	treatment: untreated	timepoint: 3 hrs	subject: 1	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	5_1_3_Untreated	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025022	1C			B	0	1		0			gardiquimod;BTKi (RN486)	3h	5 uM;1 uM	dendritic cells	pDC_Gard_Btki_3hrs_donor_1 (7_1_3)	"pDC from donor 1, gardiquimod_Btki, 3 hrs"	NA	treatment: gardiquimod and BTK inhibitor	timepoint: 3 hrs	subject: 1	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	7_1_3_Gard_Btki	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025023	1C			A	0	1		0			gardiquimod	3h	5 uM	dendritic cells	pDC_Gard_3hrs_donor_1 (8_1_3)	"pDC from donor 1, gardiquimod, 3 hrs"	NA	treatment: gardiquimod	timepoint: 3 hrs	subject: 1	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	8_1_3_Gard	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025024	1C			C	0	1		0			ODN2216	3h	1 uM	dendritic cells	pDC_ODN2216_3hrs_donor_1 (10_1_3)	"pDC from donor 1, ODN 2216, 3 hrs"	NA	treatment: ODN 2216	timepoint: 3 hrs	subject: 1	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	10_1_3_2216	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025025	1C			B	0	1		0			gardiquimod;BTKi (RN486)	3h	5 uM;1 uM	dendritic cells	pDC_ODN2216_Btki_3hrs_donor_1 (13_1_3)	"pDC from donor 1, ODN 2216_Btki, 3 hrs"	NA	treatment: ODN 2216 and BTK inhibitor	timepoint: 3 hrs	subject: 1	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	13_1_3_2216_Btki	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025026	1C			a	0	1		1			(Veh)	3h		dendritic cells	pDC_Untreated_3hrs_donor_1 (15_1_3)	"pDC from donor 1, untreated, 3 hrs"	NA	treatment: untreated	timepoint: 3 hrs	subject: 1	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	15_1_3_Untreated	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025027	1C			B	0	1		0			gardiquimod;BTKi (RN486)	3h	5 uM;1 uM	dendritic cells	pDC_ODN2216_Btki_3hrs_donor_2 (17_2_3)	"pDC from donor 2, ODN 2216_Btki, 3 hrs"	NA	treatment: ODN 2216 and BTK inhibitor	timepoint: 3 hrs	subject: 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	17_2_3_2216_Btki	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025028	1C			A	0	1		0			gardiquimod	3h	5 uM	dendritic cells	pDC_Gard_3hrs_donor_2 (21_2_3)	"pDC from donor 2, gardiquimod, 3 hrs"	NA	treatment: gardiquimod	timepoint: 3 hrs	subject: 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	21_2_3_Gard	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025029	1C			a	0	1		1			(Veh)	3h		dendritic cells	pDC_Untreated_3hrs_donor_2 (22_2_3)	"pDC from donor 2, untreated, 3 hrs"	NA	treatment: untreated	timepoint: 3 hrs	subject: 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	22_2_3_Untreated	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025030	1C			B	0	1		0			gardiquimod;BTKi (RN486)	3h	5 uM;1 uM	dendritic cells	pDC_Gard_Btki_3hrs_donor_2 (25_2_3)	"pDC from donor 2, gardiquimod_Btki, 3 hrs"	NA	treatment: gardiquimod and BTK inhibitor	timepoint: 3 hrs	subject: 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	25_2_3_Gard_Btki	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025031	1C			C	0	1		0			ODN2216	3h	1 uM	dendritic cells	pDC_ODN2216_3hrs_donor_2 (26_2_3)	"pDC from donor 2, ODN 2216, 3 hrs"	NA	treatment: ODN 2216	timepoint: 3 hrs	subject: 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	26_2_3_2216	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025032	1C			A	0	1		0			gardiquimod	3h	5 uM	dendritic cells	pDC_Gard_3hrs_donor_2 (27_2_3)	"pDC from donor 2, gardiquimod, 3 hrs"	NA	treatment: gardiquimod	timepoint: 3 hrs	subject: 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	27_2_3_Gard	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025033	1C			a	0	1		1			(Veh)	3h		dendritic cells	pDC_Untreated_3hrs_donor_2 (28_2_3)	"pDC from donor 2, untreated, 3 hrs"	NA	treatment: untreated	timepoint: 3 hrs	subject: 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	28_2_3_Untreated	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025034	1C			C	0	1		0			ODN2216	3h	1 uM	dendritic cells	pDC_ODN2216_3hrs_donor_2 (30_2_3)	"pDC from donor 2, ODN 2216, 3 hrs"	NA	treatment: ODN 2216	timepoint: 3 hrs	subject: 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	30_2_3_2216	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025035	1C			B	0	1		0			gardiquimod;BTKi (RN486)	3h	5 uM;1 uM	dendritic cells	pDC_ODN2216_Btki_3hrs_donor_3 (33_3_3)	"pDC from donor 3, ODN 2216_Btki, 3 hrs"	NA	treatment: ODN 2216 and BTK inhibitor	timepoint: 3 hrs	subject: 3	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	33_3_3_2216_Btki	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025036	1C			a	0	1		1			(Veh)	3h		dendritic cells	pDC_Untreated_3hrs_donor_3 (36_3_3)	"pDC from donor 3, untreated, 3 hrs"	NA	treatment: untreated	timepoint: 3 hrs	subject: 3	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	36_3_3_Untreated	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025037	1C			A	0	1		0			gardiquimod	3h	5 uM	dendritic cells	pDC_Gard_3hrs_donor_3 (37_3_3)	"pDC from donor 3, gardiquimod, 3 hrs"	NA	treatment: gardiquimod	timepoint: 3 hrs	subject: 3	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	37_3_3_Gard	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025038	1C			C	0	1		0			ODN2216	3h	1 uM	dendritic cells	pDC_ODN2216_3hrs_donor_3 (38_3_3)	"pDC from donor 3, ODN 2216, 3 hrs"	NA	treatment: ODN 2216	timepoint: 3 hrs	subject: 3	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	38_3_3_2216	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025039	1C			B	0	1		0			gardiquimod;BTKi (RN486)	3h	5 uM;1 uM	dendritic cells	pDC_ODN2216_Btki_3hrs_donor_3 (39_3_3)	"pDC from donor 3, ODN 2216_Btki, 3 hrs"	NA	treatment: ODN 2216 and BTK inhibitor	timepoint: 3 hrs	subject: 3	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	39_3_3_2216_Btki	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025040	1C			a	0	1		1			(Veh)	3h		dendritic cells	pDC_Untreated_3hrs_donor_3 (41_3_3)	"pDC from donor 3, untreated, 3 hrs"	NA	treatment: untreated	timepoint: 3 hrs	subject: 3	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	41_3_3_Untreated	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025041	1C			B	0	1		0			gardiquimod;BTKi (RN486)	3h	5 uM;1 uM	dendritic cells	pDC_Gard_Btki_3hrs_donor_3 (44_3_3)	"pDC from donor 3, gardiquimod_Btki, 3 hrs"	NA	treatment: gardiquimod and BTK inhibitor	timepoint: 3 hrs	subject: 3	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	44_3_3_Gard_Btki	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025042	1C			C	0	1		0			ODN2216	3h	1 uM	dendritic cells	pDC_ODN2216_3hrs_donor_3 (50_3_3)	"pDC from donor 3, ODN 2216, 3 hrs"	NA	treatment: ODN 2216	timepoint: 3 hrs	subject: 3	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	50_3_3_2216	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025043	1C			A	0	1		0			gardiquimod	3h	5 uM	dendritic cells	pDC_Gard_3hrs_donor_3 (52_3_3)	"pDC from donor 3, gardiquimod, 3 hrs"	NA	treatment: gardiquimod	timepoint: 3 hrs	subject: 3	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	52_3_3_Gard	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025044	1C			A	0	1		0			gardiquimod	3h	5 uM	dendritic cells	pDC_Gard_3hrs_donor_4 (53_4_3)	"pDC from donor 4, gardiquimod, 3 hrs"	NA	treatment: gardiquimod	timepoint: 3 hrs	subject: 4	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	53_4_3_Gard	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025045	1C			C	0	1		0			ODN2216	3h	1 uM	dendritic cells	pDC_ODN2216_3hrs_donor_4 (57_4_3)	"pDC from donor 4, ODN 2216, 3 hrs"	NA	treatment: ODN 2216	timepoint: 3 hrs	subject: 4	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	57_4_3_2216	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025046	1C			B	0	1		0			gardiquimod;BTKi (RN486)	3h	5 uM;1 uM	dendritic cells	pDC_Gard_Btki_3hrs_donor_4 (59_4_3)	"pDC from donor 4, gardiquimod_Btki, 3 hrs"	NA	treatment: gardiquimod and BTK inhibitor	timepoint: 3 hrs	subject: 4	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	59_4_3_Gard_Btki	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025047	1C			a	0	1		1			(Veh)	3h		dendritic cells	pDC_Untreated_3hrs_donor_4 (60_4_3)	"pDC from donor 4, untreated, 3 hrs"	NA	treatment: untreated	timepoint: 3 hrs	subject: 4	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	60_4_3_Untreated	NA	NA	NA	NA	NA	NA	NA	NA
GSE41825	GSM1025048	1C			a	0	1		1			(Veh)	3h		dendritic cells	pDC_Untreated_3hrs_donor_4 (62_4_3)	"pDC from donor 4, untreated, 3 hrs"	NA	treatment: untreated	timepoint: 3 hrs	subject: 4	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell type: plasmacytoid dendritic cells (pDCs)	NA	GPL570	NA	62_4_3_Untreated	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE77145	GSM2044794	1C			A	0	1		0	TBX21	LOF	ODN1826;IFNg	20h	1 uM;10 ng/ml	B lymphocytes	TbetKO_CpG_IFNG_rep1	"splenic follicular B cells, Tbet KO, IFNG"	NA	genotype/variation: Tbx21-/-	cell type: splenic follicular B cells	treatment: interferon-gamma (IFNG)	Sex: female	NA	NA	NA	NA	NA	NA	NA	NA	strain/background: C57BL/6	NA	GPL6885	NA	3999437115_A	NA	NA	NA	NA	NA	NA	NA	NA
GSE77145	GSM2044795	1C			B	0	1		0	TBX21	LOF	ODN1826;IL21	20h	25 ng/ml	B lymphocytes	TbetKO_CpG_IL21_rep1	"splenic follicular B cells, Tbet KO, IL21"	NA	genotype/variation: Tbx21-/-	cell type: splenic follicular B cells	treatment: interleukin-21 (IL21)	Sex: female	NA	NA	NA	NA	NA	NA	NA	NA	strain/background: C57BL/6	NA	GPL6885	NA	3999437115_B	NA	NA	NA	NA	NA	NA	NA	NA
GSE77145	GSM2044796	1C			A	0	1		0	TBX21	LOF	ODN1826;IFNg	20h	1 uM;10 ng/ml	B lymphocytes	TbetKO_CpG_IFNG_rep2	"splenic follicular B cells, Tbet KO, IFNG"	NA	genotype/variation: Tbx21-/-	cell type: splenic follicular B cells	treatment: interferon-gamma (IFNG)	Sex: female	NA	NA	NA	NA	NA	NA	NA	NA	strain/background: C57BL/6	NA	GPL6885	NA	3999437115_C	NA	NA	NA	NA	NA	NA	NA	NA
GSE77145	GSM2044797	1C			B	0	1		0	TBX21	LOF	ODN1826;IL21	20h	25 ng/ml	B lymphocytes	TbetKO_CpG_IL21_rep2	"splenic follicular B cells, Tbet KO, IL21"	NA	genotype/variation: Tbx21-/-	cell type: splenic follicular B cells	treatment: interleukin-21 (IL21)	Sex: female	NA	NA	NA	NA	NA	NA	NA	NA	strain/background: C57BL/6	NA	GPL6885	NA	3999437115_D	NA	NA	NA	NA	NA	NA	NA	NA
GSE77145	GSM2044798	1C			a	0	1		1	(WT)		ODN1826;IFNg	20h	1 uM;10 ng/ml	B lymphocytes	WT_CpG_IFNG_rep1	"splenic follicular B cells, WT, IFNG"	NA	genotype/variation: Tbx21+/+	cell type: splenic follicular B cells	treatment: interferon-gamma (IFNG)	Sex: female	NA	NA	NA	NA	NA	NA	NA	NA	strain/background: C57BL/6	NA	GPL6885	NA	3999437115_E	NA	NA	NA	NA	NA	NA	NA	NA
GSE77145	GSM2044799	1C			b	0	1		1	(WT)		ODN1826;IL21	20h	25 ng/ml	B lymphocytes	WT_CpG_IL21_rep1	"splenic follicular B cells, WT, IL21"	NA	genotype/variation: Tbx21+/+	cell type: splenic follicular B cells	treatment: interleukin-21 (IL21)	Sex: female	NA	NA	NA	NA	NA	NA	NA	NA	strain/background: C57BL/6	NA	GPL6885	NA	3999437115_F	NA	NA	NA	NA	NA	NA	NA	NA
GSE77145	GSM2044800	1C			a	0	1		1	(WT)		ODN1826;IFNg	20h	1 uM;10 ng/ml	B lymphocytes	WT_CpG_IFNG_rep2	"splenic follicular B cells, WT, IFNG"	NA	genotype/variation: Tbx21+/+	cell type: splenic follicular B cells	treatment: interferon-gamma (IFNG)	Sex: female	NA	NA	NA	NA	NA	NA	NA	NA	strain/background: C57BL/6	NA	GPL6885	NA	3999437115_G	NA	NA	NA	NA	NA	NA	NA	NA
GSE77145	GSM2044801	1C			b	0	1		1	(WT)		ODN1826;IL21	20h	25 ng/ml	B lymphocytes	WT_CpG_IL21_rep2	"splenic follicular B cells, WT, IL21"	NA	genotype/variation: Tbx21+/+	cell type: splenic follicular B cells	treatment: interleukin-21 (IL21)	Sex: female	NA	NA	NA	NA	NA	NA	NA	NA	strain/background: C57BL/6	NA	GPL6885	NA	3999437115_H	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE79272	GSM2090431	Htseq			B	0	1		0			CpG	18h	0.5 uM	dendritic cells	Healthy donor 1 pDCs stimulated with CpG	plasmacytoid dendritic cells	NA	tissue: blood	donor: 1	gender: female	stimulus: CPG	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	CPG1_C800HANXX_CGATGT_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090432	Htseq			B	0	1		0			CpG	18h	0.5 uM	dendritic cells	Healthy donor 2 pDCs stimulated with CpG	plasmacytoid dendritic cells	NA	tissue: blood	donor: 2	gender: female	stimulus: CPG	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	CPG2_C800HANXX_ACAGTG_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090433	Htseq			B	0	1		0			CpG	18h	0.5 uM	dendritic cells	Healthy donor 4 pDCs stimulated with CpG	plasmacytoid dendritic cells	NA	tissue: blood	donor: 4	gender: male	stimulus: CPG	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	CPG4_C800HANXX_ACTTGA_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090434	Htseq			B	0	1		0			CpG	18h	0.5 uM	dendritic cells	Healthy donor 5 pDCs stimulated with CpG	plasmacytoid dendritic cells	NA	tissue: blood	donor: 5	gender: female	stimulus: CPG	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	CPG5_C800HANXX_GGCTAC_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090435	Htseq			B	0	1		0			CpG	18h	0.5 uM	dendritic cells	Healthy donor 6 pDCs stimulated with CpG	plasmacytoid dendritic cells	NA	tissue: blood	donor: 6	gender: female	stimulus: CPG	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	CPG6_C800HANXX_AGTTCC_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090436	Htseq			B	0	1		0			CpG	18h	0.5 uM	dendritic cells	Healthy donor 7 pDCs stimulated with CpG	plasmacytoid dendritic cells	NA	tissue: blood	donor: 7	gender: male	stimulus: CPG	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	CPG7_C800HANXX_GTCCGC_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090437	Htseq			C	0	1		0			imiquimod	18h	0.5 ug/ml	dendritic cells	Healthy donor 1 pDCs stimulated with IMQ	plasmacytoid dendritic cells	NA	tissue: blood	donor: 1	gender: female	stimulus: IMQ	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	IMQ1_C800HANXX_TTAGGC_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090438	Htseq			C	0	1		0			imiquimod	18h	0.5 ug/ml	dendritic cells	Healthy donor 2 pDCs stimulated with IMQ	plasmacytoid dendritic cells	NA	tissue: blood	donor: 2	gender: female	stimulus: IMQ	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	IMQ2_C800HANXX_GCCAAT_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090439	Htseq			C	0	1		0			imiquimod	18h	0.5 ug/ml	dendritic cells	Healthy donor 4 pDCs stimulated with IMQ	plasmacytoid dendritic cells	NA	tissue: blood	donor: 4	gender: male	stimulus: IMQ	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	IMQ4_C800HANXX_GATCAG_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090440	Htseq			C	0	1		0			imiquimod	18h	0.5 ug/ml	dendritic cells	Healthy donor 5 pDCs stimulated with IMQ	plasmacytoid dendritic cells	NA	tissue: blood	donor: 5	gender: female	stimulus: IMQ	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	IMQ5_C800HANXX_CTTGTA_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090441	Htseq			C	0	1		0			imiquimod	18h	0.5 ug/ml	dendritic cells	Healthy donor 6 pDCs stimulated with IMQ	plasmacytoid dendritic cells	NA	tissue: blood	donor: 6	gender: female	stimulus: IMQ	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	IMQ6_C800HANXX_ATGTCA_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090442	Htseq			C	0	1		0			imiquimod	18h	0.5 ug/ml	dendritic cells	Healthy donor 7 pDCs stimulated with IMQ	plasmacytoid dendritic cells	NA	tissue: blood	donor: 7	gender: male	stimulus: IMQ	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	IMQ7_C800HANXX_GTGAAA_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090443	Htseq			A	0	1		0			(Veh)	18h		dendritic cells	Healthy donor 1 pDCs	plasmacytoid dendritic cells	NA	tissue: blood	donor: 1	gender: female	stimulus: UT	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	UT1_C800HANXX_ATCACG_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090444	Htseq			A	0	1		0			(Veh)	18h		dendritic cells	Healthy donor 2 pDCs	plasmacytoid dendritic cells	NA	tissue: blood	donor: 2	gender: female	stimulus: UT	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	UT2_C800HANXX_TGACCA_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090445	Htseq			A	0	1		0			(Veh)	18h		dendritic cells	Healthy donor 4 pDCs	plasmacytoid dendritic cells	NA	tissue: blood	donor: 4	gender: male	stimulus: UT	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	UT4_C800HANXX_CAGATC_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090446	Htseq			A	0	1		0			(Veh)	18h		dendritic cells	Healthy donor 5 pDCs	plasmacytoid dendritic cells	NA	tissue: blood	donor: 5	gender: female	stimulus: UT	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	UT5_C800HANXX_TAGCTT_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090447	Htseq			A	0	1		0			(Veh)	18h		dendritic cells	Healthy donor 6 pDCs	plasmacytoid dendritic cells	NA	tissue: blood	donor: 6	gender: female	stimulus: UT	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	UT6_C800HANXX_AGTCAA_L004	NA	NA	NA	NA	NA	NA	NA	NA
GSE79272	GSM2090448	Htseq			A	0	1		0			(Veh)	18h		dendritic cells	Healthy donor 7 pDCs	plasmacytoid dendritic cells	NA	tissue: blood	donor: 7	gender: male	stimulus: UT	NA	NA	NA	NA	NA	NA	NA	NA	cell type: pDCs	NA	GPL16791	NA	UT7_C800HANXX_CCGTCC_L004	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE81527	GSM2155122	1C			b	0	1		1			gardiquimod	5h	5 ug/ml	PBMC	IRAK4_EPH06P1_hPBMC_GARD_vehicle_D122_2C	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D122	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155123	1C			A	0	1		0			BMS-986126;gardiquimod	30m;5h	5 uM;5 ug/ml	PBMC	IRAK4_EPH03P1_hPBMC_GARD_BMT087965_D122_5C	Human Donor PBMC	NA	tissue: PBMC	pretreated with: 5uM BMS-986126 (BMT-087965) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D122	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155124	1C			a	0	1		1			(Veh)			PBMC	IRAK4_EPG05P1_hPBMC_unstim_vehicle_D140_1E	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: none (unstimulated)	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D140	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155125	1C			a	0	1		1			(Veh)			PBMC	IRAK4_EPG04P1_hPBMC_unstim_vehicle_D140_1F	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: none (unstimulated)	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D140	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155126	1C			b	0	1		1			gardiquimod	5h	5 ug/ml	PBMC	IRAK4_EPG02P1_hPBMC_GARD_vehicle_D140_2G	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D140	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155127	1C			a	0	1		1			(Veh)			PBMC	IRAK4_EPG01P1_hPBMC_unstim_vehicle_D122_1D	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: none (unstimulated)	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D122	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155128	1C			A	0	1		0			BMS-986126;gardiquimod	30m;5h	5 uM;5 ug/ml	PBMC	IRAK4_EPF02P1_hPBMC_GARD_BMT087965_D122_5B	Human Donor PBMC	NA	tissue: PBMC	pretreated with: 5uM BMS-986126 (BMT-087965) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D122	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155129	1C			a	0	1		1			(Veh)			PBMC	IRAK4_EPF01P1_hPBMC_unstim_vehicle_D122_1B	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: none (unstimulated)	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D122	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155130	1C			a	0	1		1			(Veh)			PBMC	IRAK4_EPE07P1_hPBMC_unstim_vehicle_D122_1C	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: none (unstimulated)	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D122	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155131	1C			A	0	1		0			BMS-986126;gardiquimod	30m;5h	5 uM;5 ug/ml	PBMC	IRAK4_EPE04P1_hPBMC_GARD_BMT087965_D122_5D	Human Donor PBMC	NA	tissue: PBMC	pretreated with: 5uM BMS-986126 (BMT-087965) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D122	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155132	1C			a	0	1		1			(Veh)			PBMC	IRAK4_EPD07P1_hPBMC_unstim_vehicle_D140_1G	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: none (unstimulated)	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D140	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155133	1C			b	0	1		1			gardiquimod	5h	5 ug/ml	PBMC	IRAK4_EPD06P1_hPBMC_GARD_vehicle_D140_2E	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D140	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155134	1C			b	0	1		1			gardiquimod	5h	5 ug/ml	PBMC	IRAK4_EPD01P1_hPBMC_GARD_vehicle_D140_2F	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D140	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155135	1C			A	0	1		0			BMS-986126;gardiquimod	30m;5h	5 uM;5 ug/ml	PBMC	IRAK4_EPC05P1_hPBMC_GARD_BMT087965_D140_5G	Human Donor PBMC	NA	tissue: PBMC	pretreated with: 5uM BMS-986126 (BMT-087965) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D140	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155136	1C			A	0	1		0			BMS-986126;gardiquimod	30m;5h	5 uM;5 ug/ml	PBMC	IRAK4_EPC04P1_hPBMC_GARD_BMT087965_D140_5E	Human Donor PBMC	NA	tissue: PBMC	pretreated with: 5uM BMS-986126 (BMT-087965) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D140	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155137	1C			b	0	1		1			gardiquimod	5h	5 ug/ml	PBMC	IRAK4_EPB07P1_hPBMC_GARD_vehicle_D122_2B	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D122	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155138	1C			b	0	1		1			gardiquimod	5h	5 ug/ml	PBMC	IRAK4_EPB01P1_hPBMC_GARD_vehicle_D122_2D	Human Donor PBMC	NA	tissue: PBMC	pretreated with: DMSO (vehicle) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D122	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE81527	GSM2155139	1C			A	0	1		0			BMS-986126;gardiquimod	30m;5h	5 uM;5 ug/ml	PBMC	IRAK4_EPA02P1_hPBMC_GARD_BMT087965_D140_5F	Human Donor PBMC	NA	tissue: PBMC	pretreated with: 5uM BMS-986126 (BMT-087965) for 30 min at 37C	stimulated with: 5ug/ml gardiquimod for 5hrs	NA	NA	NA	NA	NA	NA	NA	NA	NA	donor id: D140	NA	GPL13667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE94380	GSM2474339	1C			A	0	1		0			(Veh)			CD11b+ dendritic cells	"WT Peyer's patch CD11b+ cDC, steady state, replicate 1"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11bintCD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD11b+ cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474340	1C			A	0	1		0			(Veh)			CD11b+ dendritic cells	"WT Peyer's patch CD11b+ cDC, steady state, replicate 2"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11bintCD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD11b+ cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474341	1C			A	0	1		0			(Veh)			CD11b+ dendritic cells	"WT Peyer's patch CD11b+ cDC, steady state, replicate 3"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11bintCD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD11b+ cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474342	1C			A	0	1		0			(Veh)			CD11b+ dendritic cells	"WT Peyer's patch CD11b+ cDC, steady state, replicate 4"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11bintCD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD11b+ cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474343	1C			A	0	1		0			(Veh)			CD11b+ dendritic cells	"WT Peyer's patch CD11b+ cDC, steady state, replicate 5"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11bintCD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD11b+ cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474344	1C				1	1		0			(Veh)			DN cDC	"WT Peyer's patch DN cDC, steady state, replicate 1"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: SED and/or IFR	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11b-CD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch DN cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474345	1C				1	1		0			(Veh)			DN cDC	"WT Peyer's patch DN cDC, steady state, replicate 2"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: SED and/or IFR	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11b-CD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch DN cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474346	1C				1	1		0			(Veh)			DN cDC	"WT Peyer's patch DN cDC, steady state, replicate 3"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: SED and/or IFR	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11b-CD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch DN cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474347	1C			A	0	1		0			(Veh)			CD8a+ dendritic cells	"WT Peyer's patch CD8a+ cDC, steady state, replicate 1"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa-BST2-CD11b-CD8a+CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD8a+ cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474348	1C			A	0	1		0			(Veh)			CD8a+ dendritic cells	"WT Peyer's patch CD8a+ cDC, steady state, replicate 2"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa-BST2-CD11b-CD8a+CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD8a+ cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474349	1C			A	0	1		0			(Veh)			CD8a+ dendritic cells	"WT Peyer's patch CD8a+ cDC, steady state, replicate 3"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa-BST2-CD11b-CD8a+CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD8a+ cDC at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474350	1C				1	1		0			(Veh)			LysoMac	"WT Peyer's patch TIM-4- LysoMac, steady state, replicate 1"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Subepithelial dome (SED)	treatment: None	cell type: Macrophage	phenotype: CD11chiMHCIIloSIRPa+BST2+CD4+TIM4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch TIM4- macrophages at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474351	1C				1	1		0			(Veh)			LysoMac	"WT Peyer's patch TIM-4- LysoMac, steady state, replicate 2"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Subepithelial dome (SED)	treatment: None	cell type: Macrophage	phenotype: CD11chiMHCIIloSIRPa+BST2+CD4+TIM4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch TIM4- macrophages at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474352	1C				1	1		0			(Veh)			LysoMac	"WT Peyer's patch TIM-4- LysoMac, steady state, replicate 3"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Subepithelial dome (SED)	treatment: None	cell type: Macrophage	phenotype: CD11chiMHCIIloSIRPa+BST2+CD4+TIM4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch TIM4- macrophages at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474353	1C				1	1		0			(Veh)			LysoMac	"WT Peyer's patch TIM-4+ LysoMac, steady state, replicate 1"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Macrophage	phenotype: CD11chiMHCIIloSIRPa+BST2+CD4+TIM4+	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch TIM4+ macrophages at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474354	1C				1	1		0			(Veh)			LysoMac	"WT Peyer's patch TIM-4+ LysoMac, steady state, replicate 2"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Macrophage	phenotype: CD11chiMHCIIloSIRPa+BST2+CD4+TIM4+	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch TIM4+ macrophages at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474355	1C				1	1		0			(Veh)			LysoMac	"WT Peyer's patch TIM-4+ LysoMac, steady state, replicate 3"	"Mouse Peyer's patch, steady state"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: None	cell type: Macrophage	phenotype: CD11chiMHCIIloSIRPa+BST2+CD4+TIM4+	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch TIM4+ macrophages at steady state	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474356	1C			B	0	1		0			R848	9h	10 ug	CD11b+ dendritic cells	"WT R848-treated Peyer's patch CD11b+ cDC, steady state, replicate 1"	"Mouse Peyer's patch, R848, 9h"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: 9h R848	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11bintCD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD11b+ cDC 9h after R848 treatment	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474357	1C			B	0	1		0			R848	9h	10 ug	CD11b+ dendritic cells	"WT R848-treated Peyer's patch CD11b+ cDC, steady state, replicate 2"	"Mouse Peyer's patch, R848, 9h"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: 9h R848	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11bintCD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD11b+ cDC 9h after R848 treatment	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474358	1C			B	0	1		0			R848	9h	10 ug	CD11b+ dendritic cells	"WT R848-treated Peyer's patch CD11b+ cDC, steady state, replicate 3"	"Mouse Peyer's patch, R848, 9h"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: 9h R848	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa+BST2-CD11bintCD8a-CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD11b+ cDC 9h after R848 treatment	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474359	1C			B	0	1		0			R848	9h	10 ug	CD8a+ dendritic cells	"WT R848-treated Peyer's patch CD8a+ cDC, steady state, replicate 1"	"Mouse Peyer's patch, R848, 9h"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: 9h R848	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa-BST2-CD11b-CD8a+CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD8a+ cDC 9h after R848 treatment	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474360	1C			B	0	1		0			R848	9h	10 ug	CD8a+ dendritic cells	"WT R848-treated Peyer's patch CD8a+ cDC, steady state, replicate 2"	"Mouse Peyer's patch, R848, 9h"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: 9h R848	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa-BST2-CD11b-CD8a+CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD8a+ cDC 9h after R848 treatment	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474361	1C			B	0	1		0			R848	9h	10 ug	CD8a+ dendritic cells	"WT R848-treated Peyer's patch CD8a+ cDC, steady state, replicate 3"	"Mouse Peyer's patch, R848, 9h"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: 9h R848	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa-BST2-CD11b-CD8a+CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD8a+ cDC 9h after R848 treatment	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474362	1C			B	0	1		0			R848	9h	10 ug	CD8a+ dendritic cells	"WT R848-treated Peyer's patch CD8a+ cDC, steady state, replicate 4"	"Mouse Peyer's patch, R848, 9h"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: 9h R848	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa-BST2-CD11b-CD8a+CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD8a+ cDC 9h after R848 treatment	NA	NA	NA	NA	NA	NA	NA	NA
GSE94380	GSM2474363	1C			B	0	1		0			R848	9h	10 ug	CD8a+ dendritic cells	"WT R848-treated Peyer's patch CD8a+ cDC, steady state, replicate 5"	"Mouse Peyer's patch, R848, 9h"	NA	gender: Female	age: 6 to 8 weeks-old	tissue: Peyer's patch	main location: Interfollicular region (IFR; T cell zone)	treatment: 9h R848	cell type: Dendritic Cell	phenotype: CD11chiMHCII+SIRPa-BST2-CD11b-CD8a+CD4-	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Peyer's patch CD8a+ cDC 9h after R848 treatment	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE7831	GSM190131	1C			a	0	1		1			(Veh)	1h		dendritic cells	"pDC medium 1h, biological rep1"	pDC cultured in medium for 1h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from plasmacytoid dendritic cells at baseline (medium 1h)	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190132	1C			a	0	1		1			(Veh)	1h		dendritic cells	"pDC medium 1h, biological rep2"	pDC cultured in medium for 1h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from plasmacytoid dendritic cells at baseline (medium 1h)	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190133	1C			A	0	1		0			CpG1826	1h	5 ug/ml	dendritic cells	"pDC CpG 1h, biological rep1"	pDC cultured in medium with CpG for 1h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from activated plasmacytoid dendritic cells with CPG for 1h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190134	1C			A	0	1		0			CpG1826	1h	5 ug/ml	dendritic cells	"pDC CpG 1h, biological rep2"	pDC cultured in medium with CpG for 1h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from activated plasmacytoid dendritic cells with CPG for 1h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190135	1C			B	0	1		0			PR8 (flu)	1h	300 HAU/ml	dendritic cells	"pDC flu 1h, biological rep1"	pDC cultured in medium with PR8 (flu) for 1h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from activated plasmacytoid dendritic cells with influenza A/PR8 virus  (flu) for 1h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190136	1C			B	0	1		0			PR8 (flu)	1h	300 HAU/ml	dendritic cells	"pDC flu 1h, biological rep2"	pDC cultured in medium with PR8 (flu) for 1h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from activated plasmacytoid dendritic cells with influenza A/PR8 virus  (flu) for 1h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190137	1C			b	0	1		1			(Veh)	4h		dendritic cells	"pDC medium 4h, biological rep1"	pDC cultured in medium for 4h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from  plasmacytoid dendritic cells cultured in medium for 4h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190138	1C			b	0	1		1			(Veh)	4h		dendritic cells	"pDC medium 4h, biological rep2"	pDC cultured in medium for 4h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from  plasmacytoid dendritic cells cultured in medium for 4h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190139	1C			b	0	1		1			(Veh)	4h		dendritic cells	"pDC medium 4h, biological rep3"	pDC cultured in medium for 4h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from  plasmacytoid dendritic cells cultured in medium for 4h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190140	1C			C	0	1		0			CpG1826	4h	5 ug/ml	dendritic cells	"pDC CpG 4h, biological rep1"	pDC cultured in medium with CpG for 4h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from  activated plasmacytoid dendritic cells cultured with CPG for 4h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190141	1C			C	0	1		0			CpG1826	4h	5 ug/ml	dendritic cells	"pDC CpG 4h, biological rep2"	pDC cultured in medium with CpG for 4h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from  activated plasmacytoid dendritic cells cultured with CPG for 4h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190142	1C			C	0	1		0			CpG1826	4h	5 ug/ml	dendritic cells	"pDC CpG 4h, biological rep3"	pDC cultured in medium with CpG for 4h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from  activated plasmacytoid dendritic cells cultured with CPG for 4h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190143	1C			D	0	1		0			PR8 (flu)	4h	300 HAU/ml	dendritic cells	"pDC flu 4h, biological rep1"	pDC cultured in medium with PR8 (flu) for 4h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from  activated plasmacytoid dendritic cells cultured with influenza A/PR/8 virus for 4h	NA	NA	NA	NA	NA	NA	NA	NA
GSE7831	GSM190144	1C			D	0	1		0			PR8 (flu)	4h	300 HAU/ml	dendritic cells	"pDC flu 4h, biological rep2"	pDC cultured in medium with PR8 (flu) for 4h	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	pDC isolated from spleen of Flt-3L-treated DPEGFPxRag1-/- mice	NA	GPL1261	NA	Gene expression data from  activated plasmacytoid dendritic cells cultured with influenza A/PR/8 virus for 4h	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE9287	GSM235399	1C			a	0	1		1	(WT)					spleen	spleen_WT_rep1	spleen cells from C57Bl/6J wild-type male	NA	Sex: male	Tissue: whole spleen tissue		NA	NA	NA	NA	NA	NA	NA	NA	NA	Strain: C57Bl/6J	NA	GPL1261	NA	This study was designed to identify gene expression between spleen cells of male mice with and without the Yaa mutation.	NA	NA	NA	NA	NA	NA	NA	NA
GSE9287	GSM236566	1C			a	0	1		1	(WT)					spleen	spleen_WT_rep2	spleen cells from C57Bl/6J wild-type male	NA	Sex: male	Tissue: whole spleen tissue		NA	NA	NA	NA	NA	NA	NA	NA	NA	Strain: C57Bl/6J	NA	GPL1261	NA	This study was designed to identify gene expression between spleen cells of male mice with and without the Yaa mutation.	NA	NA	NA	NA	NA	NA	NA	NA
GSE9287	GSM236567	1C			a	0	1		1	(WT)					spleen	spleen_WT_rep3	spleen cells from C57Bl/6J wild-type male	NA	Sex: male	Tissue: whole spleen tissue		NA	NA	NA	NA	NA	NA	NA	NA	NA	Strain: C57Bl/6J	NA	GPL1261	NA	This study was designed to identify gene expression between spleen cells of male mice with and without the Yaa mutation.	NA	NA	NA	NA	NA	NA	NA	NA
GSE9287	GSM236573	1C			a	0	1		1	(WT)					spleen	spleen_WT_rep4	spleen cells from C57Bl/6J wild-type male	NA	Sex: male	Tissue: whole spleen tissue		NA	NA	NA	NA	NA	NA	NA	NA	NA	Strain: C57Bl/6J	NA	GPL1261	NA	This study was designed to identify gene expression between spleen cells of male mice with and without the Yaa mutation.	NA	NA	NA	NA	NA	NA	NA	NA
GSE9287	GSM236620	1C			A	0	1		0	TLR7	OE				spleen	spleen_Yaa_rep1	spleen cells from B6.SB-Yaa/J male	NA	Sex: male	Tissue: whole spleen tissue		NA	NA	NA	NA	NA	NA	NA	NA	NA	Strain: B6.SB-Yaa/J	NA	GPL1261	NA	The Yaa gene is on the Y chromosome and is responsible for accelerated autoimmune disease in mice with susceptible genetic backgrounds	NA	NA	NA	NA	NA	NA	NA	NA
GSE9287	GSM236621	1C			A	0	1		0	TLR7	OE				spleen	spleen_Yaa_rep2	spleen cells from C57Bl/6 males with Yaa mutation	NA	Sex: male	Tissue: whole spleen tissue		NA	NA	NA	NA	NA	NA	NA	NA	NA	Strain: B6.SB-Yaa/J	NA	GPL1261	NA	The Yaa gene is on the Y chromosome and is responsible for accelerated autoimmune disease in mice with susceptible genetic backgrounds	NA	NA	NA	NA	NA	NA	NA	NA
GSE9287	GSM236622	1C			A	0	1		0	TLR7	OE				spleen	spleen_Yaa_rep3	spleen cells from C57Bl/6 male with Yaa mutation	NA	Sex: male	Tissue: whole spleen tissue	note: RNA in this one sample was prepared from spleenocytes from two different spleens	NA	NA	NA	NA	NA	NA	NA	NA	NA	Strain: B6.SB-Yaa/J	NA	GPL1261	NA	The Yaa gene is on the Y chromosome and is responsible for accelerated autoimmune disease in mice with susceptible genetic backgrounds	NA	NA	NA	NA	NA	NA	NA	NA
GSE9287	GSM236628	1C			A	0	1		0	TLR7	OE				spleen	spleen_Yaa_rep4	spleen cells from C57Bl/6 male with Yaa mutation	NA	Sex: male	Tissue: whole spleen tissue		NA	NA	NA	NA	NA	NA	NA	NA	NA	Strain: B6.SB-Yaa/J	NA	GPL1261	NA	The Yaa gene is on the Y chromosome and is responsible for accelerated autoimmune disease in mice with susceptible genetic backgrounds	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE13032	GSM326506	1C			a	0	1	AJ	1			(Veh)	3d		whole lung	A/J whole lung-PBS challenged-biological rep.1	"whole lung, A/J mouse, PBS challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: A/J Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, PBS challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326507	1C			a	0	1	AJ	1			(Veh)	3d		whole lung	A/J whole lung-PBS challenged-biological rep.2	"whole lung, A/J mouse, PBS challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: A/J Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, PBS challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326508	1C			a	0	1	AJ	1			(Veh)	3d		whole lung	A/J whole lung-PBS challenged-biological rep.3	"whole lung, A/J mouse, PBS challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: A/J Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, PBS challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326509	1C			a	0	1	C57B6	1			(Veh)	3d		whole lung	C57BL/6 whole lung-PBS challenged-biological rep.1	"whole lung, C57BL/6 mouse, PBS challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: C57BL/6 Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, PBS challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326510	1C			a	0	1	C57B6	1			(Veh)	3d		whole lung	C57BL/6 whole lung-PBS challenged-biological rep.2	"whole lung, C57BL/6 mouse, PBS challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: C57BL/6 Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, PBS challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326511	1C			a	0	1	C57B6	1			(Veh)	3d		whole lung	C57BL/6 whole lung-PBS challenged-biological rep.3	"whole lung, C57BL/6 mouse, PBS challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: C57BL/6 Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, PBS challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326512	1C			A	0	1	AJ	0			ovalbumin	3d	3x1%	whole lung	A/J whole lung-ovalbumin challenged-biological rep.1	"whole lung, A/J mouse, ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: A/J Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326513	1C			A	0	1	AJ	0			ovalbumin	3d	3x1%	whole lung	A/J whole lung-ovalbumin challenged-biological rep.2	"whole lung, A/J mouse, ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: A/J Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326514	1C			A	0	1	C57B6	0			ovalbumin	3d	3x1%	whole lung	C57BL/6 whole lung-ovalbumin challenged-biological rep.1	"whole lung, C57BL/6 mouse, ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: C57BL/6 Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326515	1C			A	0	1	C57B6	0			ovalbumin	3d	3x1%	whole lung	C57BL/6 whole lung-ovalbumin challenged-biological rep.2	"whole lung, C57BL/6 mouse, ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: C57BL/6 Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326516	1C			B	0	1	AJ	0			resiquimod;ovalbumin	1d;3d	100 ug;3x1%	whole lung	A/J whole lung-resiquimod treated and ovalbumin challenged-biological rep.1	"whole lung, A/J mouse, resiquimod treated and ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: A/J Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, resiquimod treated, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326517	1C			B	0	1	AJ	0			resiquimod;ovalbumin	1d;3d	100 ug;3x1%	whole lung	A/J whole lung-resiquimod treated and ovalbumin challenged-biological rep.2	"whole lung, A/J mouse, resiquimod treated and ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: A/J Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, resiquimod treated, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326518	1C			B	0	1	C57B6	0			resiquimod;ovalbumin	1d;3d	100 ug;3x1%	whole lung	C57BL/6 whole lung-resiquimod treated and ovalbumin challenged-biological rep.1	"whole lung, C57BL/6 mouse, resiquimod treated and ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: C57BL/6 Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, resiquimod treated, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326519	1C			A	0	1	AJ	0			ovalbumin	3d	3x1%	whole lung	A/J whole lung-ovalbumin challenged-biological rep.3	"whole lung, A/J mouse, ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: A/J Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326520	1C			A	0	1	C57B6	0			ovalbumin	3d	3x1%	whole lung	C57BL/6 whole lung-ovalbumin challenged-biological rep.3	"whole lung, C57BL/6 mouse, ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: C57BL/6 Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326521	1C			B	0	1	C57B6	0			resiquimod;ovalbumin	1d;3d	100 ug;3x1%	whole lung	C57BL/6 whole lung-resiquimod treated and ovalbumin challenged-biological rep.2	"whole lung, C57BL/6 mouse, resiquimod treated and ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: C57BL/6 Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, resiquimod treated, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326522	1C			B	0	1	C57B6	0			resiquimod;ovalbumin	1d;3d	100 ug;3x1%	whole lung	C57BL/6 whole lung-resiquimod treated and ovalbumin challenged-biological rep.3	"whole lung, C57BL/6 mouse, resiquimod treated and ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: C57BL/6 Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, resiquimod treated, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
GSE13032	GSM326523	1C			B	0	1	AJ	0			resiquimod;ovalbumin	1d;3d	100 ug;3x1%	whole lung	A/J whole lung-resiquimod treated and ovalbumin challenged-biological rep.3	"whole lung, A/J mouse, resiquimod treated and ovalbumin challenged"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"Strain: A/J Gender: Male Age:16 weeks Tissue: whole lung Treatment: Ovalbumin sensitized, resiquimod treated, ovalbumin challenged"	NA	GPL1261	NA	"gene expression data from the lungs of an acute mouse model of allergic asthma, and following resiquimod treatment"	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE41496	GSM1018240	1C			a	0	1		1			(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_B6_mock_1	"C57BL/6, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: wildtype	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: B6mock-1	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018241	1C			a	0	1		1			(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_B6_mock_2	"C57BL/6, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: wildtype	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: B6mock-2	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018242	1C			a	0	1		1			(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_B6_mock_3	"C57BL/6, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: wildtype	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: B6mock-3	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018243	1C			a	0	1		1			(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_B6_mock_4	"C57BL/6, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: wildtype	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: B6mock-4	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018244	1C			A	0	1		0			(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_B6_PcAS_24h_1	"C57BL/6, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: wildtype	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: B6PcAS-1	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018245	1C			A	0	1		0			(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_B6_PcAS_24h_2	"C57BL/6, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: wildtype	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: B6PcAS-2	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018246	1C			A	0	1		0			(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_B6_PcAS_24h_3	"C57BL/6, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: wildtype	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: B6PcAS-3	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018247	1C			A	0	1		0			(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_B6_PcAS_24h_4	"C57BL/6, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: wildtype	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: B6PcAS-4	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018248	1C			c	0	1		1	TLR9	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Tlr9_mock_1	"Tlr9 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr9 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T9mock-1	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018249	1C			c	0	1		1	TLR9	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Tlr9_mock_2	"Tlr9 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr9 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T9mock-2	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018250	1C			c	0	1		1	TLR9	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Tlr9_mock_3	"Tlr9 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr9 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T9mock-3	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018251	1C			c	0	1		1	TLR9	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Tlr9_mock_4	"Tlr9 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr9 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T9mock-4	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018252	1C			E	0	1		0	TLR9	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Tlr9_PcAS_24h_1	"Tlr9 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr9 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T9PcAS-1	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018253	1C			E	0	1		0	TLR9	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Tlr9_PcAS_24h_2	"Tlr9 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr9 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T9PcAS-2	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018254	1C			E	0	1		0	TLR9	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Tlr9_PcAS_24h_3	"Tlr9 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr9 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T9PcAS-3	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018255	1C			E	0	1		0	TLR9	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Tlr9_PcAS_24h_4	"Tlr9 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr9 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T9PcAS-4	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018256	1C			b	0	1		1	TLR7	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Tlr7_mock_1	"Tlr7 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr7 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T7mock-1	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018257	1C			b	0	1		1	TLR7	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Tlr7_mock_2	"Tlr7 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr7 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T7mock-2	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018258	1C			b	0	1		1	TLR7	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Tlr7_mock_3	"Tlr7 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr7 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T7mock-3	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018259	1C			b	0	1		1	TLR7	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Tlr7_mock_4	"Tlr7 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr7 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T7mock-4	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018260	1C			D	0	1		0	TLR7	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Tlr7_PcAS_24h_1	"Tlr7 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr7 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T7PcAS-1	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018261	1C			D	0	1		0	TLR7	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Tlr7_PcAS_24h_2	"Tlr7 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr7 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T7PcAS-2	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018262	1C			D	0	1		0	TLR7	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Tlr7_PcAS_24h_3	"Tlr7 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr7 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T7PcAS-3	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018263	1C			D	0	1		0	TLR7	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Tlr7_PcAS_24h_4	"Tlr7 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Tlr7 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: T7PcAS-4	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018264	1C			d	0	1		1	Unc93b	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Unc93b1_mock_1	"Unc93b1-3d, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Unc93b1 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Uncmock-1	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018265	1C			d	0	1		1	Unc93b	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Unc93b1_mock_2	"Unc93b1-3d, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Unc93b1 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Uncmock-2	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018266	1C			d	0	1		1	Unc93b	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Unc93b1_mock_3	"Unc93b1-3d, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Unc93b1 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Uncmock-3	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018267	1C			d	0	1		1	Unc93b	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Unc93b1_mock_4	"Unc93b1-3d, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Unc93b1 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Uncmock-4	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018268	1C			F	0	1		0	Unc93b	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Unc93b1_PcAS_24h_1	"Unc93b1-3d, whole spleen, P. chabaudi infection , 24h"	NA	background strain: C57BL/6	genotype/variation: Unc93b1 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: UncPcAS-1	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018269	1C			F	0	1		0	Unc93b	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Unc93b1_PcAS_24h_2	"Unc93b1-3d, whole spleen, P. chabaudi infection , 24h"	NA	background strain: C57BL/6	genotype/variation: Unc93b1 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: UncPcAS-2	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018270	1C			F	0	1		0	Unc93b	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Unc93b1_PcAS_24h_3	"Unc93b1-3d, whole spleen, P. chabaudi infection , 24h"	NA	background strain: C57BL/6	genotype/variation: Unc93b1 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: UncPcAS-3	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018271	1C			F	0	1		0	Unc93b	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Unc93b1_PcAS_24h_4	"Unc93b1-3d, whole spleen, P. chabaudi infection , 24h"	NA	background strain: C57BL/6	genotype/variation: Unc93b1 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: UncPcAS-4	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018272	1C			B	0	1		0	MYD88	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Myd88_mock_1	"Myd88 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Myd88 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Myd88mock-1	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018273	1C			B	0	1		0	MYD88	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Myd88_mock_2	"Myd88 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Myd88 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Myd88mock-2	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018274	1C			B	0	1		0	MYD88	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Myd88_mock_3	"Myd88 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Myd88 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Myd88mock-3	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018275	1C			B	0	1		0	MYD88	LOF	(Veh)	24h	10^6 uninfected erythrocytes	whole spleen	spleen_Myd88_mock_4	"Myd88 knockout, whole spleen, mock infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Myd88 knockout	tissue: spleen	infection: mock	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Myd88mock-4	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018276	1C			C	0	1		0	MYD88	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Myd88_PcAS_24h_1	"Myd88 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Myd88 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Myd88PcAS-1	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018277	1C			C	0	1		0	MYD88	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Myd88_PcAS_24h_2	"Myd88 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Myd88 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Myd88PcAS-2	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018278	1C			C	0	1		0	MYD88	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Myd88_PcAS_24h_3	"Myd88 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Myd88 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Myd88PcAS-3	NA	NA	NA	NA	NA	NA	NA	NA
GSE41496	GSM1018279	1C			C	0	1		0	MYD88	LOF	P. chabaudi AS (MRA-429)	24h	10^6 infected erythrocytes	whole spleen	spleen_Myd88_PcAS_24h_4	"Myd88 knockout, whole spleen, P. chabaudi infection, 24h"	NA	background strain: C57BL/6	genotype/variation: Myd88 knockout	tissue: spleen	infection: P. chabaudi	infection duration: 24h	NA	NA	NA	NA	NA	NA	NA	gender: female	NA	GPL13912	NA	Sample name: Myd88PcAS-4	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE50400	GSM1218155	1C			B	0	1		0			IL23;IMO-8400	3d	3 ug;3x15 mg/kg	skin	Sample 1	skin from IL23 mouse treated with IMO-8400	NA	treatment: IMO-8400	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with IMO-8400	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218156	1C			B	0	1		0			IL23;IMO-8400	3d	3 ug;3x15 mg/kg	skin	Sample 2	skin from IL23 mouse treated with IMO-8400	NA	treatment: IMO-8400	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with IMO-8400	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218157	1C			B	0	1		0			IL23;IMO-8400	3d	3 ug;3x15 mg/kg	skin	Sample 3	skin from IL23 mouse treated with IMO-8400	NA	treatment: IMO-8400	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with IMO-8400	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218158	1C			B	0	1		0			IL23;IMO-8400	3d	3 ug;3x15 mg/kg	skin	Sample 4	skin from IL23 mouse treated with IMO-8400	NA	treatment: IMO-8400	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with IMO-8400	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218159	1C			B	0	1		0			IL23;IMO-8400	3d	3 ug;3x15 mg/kg	skin	Sample 5	skin from IL23 mouse treated with IMO-8400	NA	treatment: IMO-8400	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with IMO-8400	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218160	1C			C	0	1		0			IL23;IMO-3100	3d	3 ug;3x15 mg/kg	skin	Sample 6	skin from IL23 mouse treated with IMO-3100	NA	treatment: IMO-3100	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with IMO-3100	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218161	1C			C	0	1		0			IL23;IMO-3100	3d	3 ug;3x15 mg/kg	skin	Sample 7	skin from IL23 mouse treated with IMO-3100	NA	treatment: IMO-3100	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with IMO-3100	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218162	1C			C	0	1		0			IL23;IMO-3100	3d	3 ug;3x15 mg/kg	skin	Sample 8	skin from IL23 mouse treated with IMO-3100	NA	treatment: IMO-3100	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with IMO-3100	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218163	1C			C	0	1		0			IL23;IMO-3100	3d	3 ug;3x15 mg/kg	skin	Sample 9	skin from IL23 mouse treated with IMO-3100	NA	treatment: IMO-3100	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with IMO-3100	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218164	1C			C	0	1		0			IL23;IMO-3100	3d	3 ug;3x15 mg/kg	skin	Sample 10	skin from IL23 mouse treated with IMO-3100	NA	treatment: IMO-3100	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with IMO-3100	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218165	1C			A	0	1		0			IL23	3d	3 ug	skin	Sample 11	skin from IL23 mouse treated with Saline	NA	treatment: saline	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with Saline	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218166	1C			A	0	1		0			IL23	3d	3 ug	skin	Sample 12	skin from IL23 mouse treated with Saline	NA	treatment: saline	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with Saline	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218167	1C			A	0	1		0			IL23	3d	3 ug	skin	Sample 13	skin from IL23 mouse treated with Saline	NA	treatment: saline	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with Saline	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218168	1C			A	0	1		0			IL23	3d	3 ug	skin	Sample 14	skin from IL23 mouse treated with Saline	NA	treatment: saline	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with Saline	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218169	1C			a	0	1		1			(Veh)	3d		skin	Sample 15	skin from IL23 mouse treated with Saline	NA	treatment: saline	condition: IL23 induced phenotype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from IL23 mouse treated with Saline	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218170	1C			a	0	1		1			(Veh)	3d		skin	Sample 16	skin from normal mouse	NA	treatment: nave	condition: Normal	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from normal mouse	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218171	1C			a	0	1		1			(Veh)	3d		skin	Sample 17	skin from normal mouse	NA	treatment: nave	condition: Normal	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from normal mouse	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218172	1C			a	0	1		1			(Veh)	3d		skin	Sample 18	skin from normal mouse	NA	treatment: nave	condition: Normal	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from normal mouse	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218173	1C			a	0	1		1			(Veh)	3d		skin	Sample 19	skin from normal mouse	NA	treatment: nave	condition: Normal	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from normal mouse	NA	NA	NA	NA	NA	NA	NA	NA
GSE50400	GSM1218174	1C			a	0	1		1			(Veh)	3d		skin	Sample 20	skin from normal mouse	NA	treatment: nave	condition: Normal	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL1261	NA	skin from normal mouse	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE47147	GSM1145709	2CDirect	Cy3		A	0	1		0	TLR7	GOF				TMD8	TMD8 shTLR7 - day 1 - mAdbID:123812	"TMD8, shTLR7, 24 hr"	"TMD8, shControl, 24 hr"	cell line: TMD8	disease state: B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL)	shRNA: shTLR7	time point: day 1	NA	NA	NA	cell line: TMD8	disease state: B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL)	shRNA: shControl	time point: day 1	NA	tissue: blood	tissue: blood	GPL4133	NA	mAdb experiment ID: 123812	NA	NA	NA	NA	NA	NA	NA	NA
GSE47147	GSM1145710	2CDirect	Cy3		A	0	1		0	TLR7	GOF				TMD8	TMD8 shTLR7 - day 2 - mAdbID:123813	"TMD8, shTLR7, 48 hr"	"TMD8, shControl, 48 hr"	cell line: TMD8	disease state: B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL)	shRNA: shTLR7	time point: day 2	NA	NA	NA	cell line: TMD8	disease state: B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL)	shRNA: shControl	time point: day 2	NA	tissue: blood	tissue: blood	GPL4133	NA	mAdb experiment ID: 123813	NA	NA	NA	NA	NA	NA	NA	NA
GSE47147	GSM1145711	2CDirect	Cy3		B	0	1		0	TLR9	GOF				TMD8	TMD8 shTLR9 - day 1 - mAdbID:123814	"TMD8, shTLR9, 24 hr"	"TMD8, shControl, 24 hr"	cell line: TMD8	disease state: B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL)	shRNA: shTLR9	time point: day 1	NA	NA	NA	cell line: TMD8	disease state: B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL)	shRNA: shControl	time point: day 1	NA	tissue: blood	tissue: blood	GPL4133	NA	mAdb experiment ID: 123814	NA	NA	NA	NA	NA	NA	NA	NA
GSE47147	GSM1145712	2CDirect	Cy3		B	0	1		0	TLR9	GOF				TMD8	TMD8 shTLR9 - day 2 - mAdbID:123815	"TMD8, shTLR9, 48 hr"	"TMD8, shControl, 48 hr"	cell line: TMD8	disease state: B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL)	shRNA: shTLR9	time point: day 2	NA	NA	NA	cell line: TMD8	disease state: B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL)	shRNA: shControl	time point: day 2	NA	tissue: blood	tissue: blood	GPL4133	NA	mAdb experiment ID: 123815	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE58756	GSM1419095	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		1	(WT)		(Veh)	0h		B lymphocytes	AM14 WT Untreated - 0 hour - mAdbID:123204	Unstimulated Pooled B-cell Control	Unstimulated AM14 WT - 0 hour	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: WT	treatment: Unstimulated	time: 0 hour	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123204	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419096	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		1	(WT)		PL2-3	6h	1 ug/ml	B lymphocytes	AM14 WT PL2-3 Treated - 6 hours - mAdbID:123205	Unstimulated Pooled B-cell Control	AM14 WT PL2-3 Treated - 6 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: WT	treatment: PL2-3	time: 6 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123205	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419097	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		1	(WT)		PL2-3	24h	1 ug/ml	B lymphocytes	AM14 WT PL2-3 Treated - 24 hours - mAdbID:123206	Unstimulated Pooled B-cell Control	AM14 WT PL2-3 Treated - 24 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: WT	treatment: PL2-3	time: 24 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123206	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419098	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		1	(WT)		PL2-3	42h	1 ug/ml	B lymphocytes	AM14 WT PL2-3 Treated - 42 hours - mAdbID:123207	Unstimulated Pooled B-cell Control	AM14 WT PL2-3 Treated - 42 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: WT	treatment: PL2-3	time: 42 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123207	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419099	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR7	LOF	(Veh)	0h		B lymphocytes	AM14 TLR7 KO Untreated - 0 hour - mAdbID:123208	Unstimulated Pooled B-cell Control	Unstimulated AM14 TLR7 KO - 0 hour	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr7-/- gene knock out	treatment: Unstimulated	time: 0 hour	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123208	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419100	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR7	LOF	PL2-3	6h	1 ug/ml	B lymphocytes	AM14 TLR7 KO PL2-3 Treated - 6 hours - mAdbID:123209	Unstimulated Pooled B-cell Control	AM14 TLR7 KO PL2-3 Treated - 6 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr7-/- gene knock out	treatment: PL2-3	time: 6 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123209	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419101	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR7	LOF	PL2-3	24h	1 ug/ml	B lymphocytes	AM14 TLR7 KO PL2-3 Treated - 24 hours - mAdbID:123210	Unstimulated Pooled B-cell Control	AM14 TLR7 KO PL2-3 Treated - 24 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr7-/- gene knock out	treatment: PL2-3	time: 24 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123210	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419102	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR7	LOF	PL2-3	42h	1 ug/ml	B lymphocytes	AM14 TLR7 KO PL2-3 Treated - 42 hours - mAdbID:123211	Unstimulated Pooled B-cell Control	AM14 TLR7 KO PL2-3 Treated - 42 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr7-/- gene knock out	treatment: PL2-3	time: 42 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123211	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419103	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR9	LOF	(Veh)	0h		B lymphocytes	AM14 TLR9 KO Untreated - 0 hour - mAdbID:123212	Unstimulated Pooled B-cell Control	Unstimulated AM14 TLR9 KO - 0 hour	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr9-/- gene knock out	treatment: Unstimulated	time: 0 hour	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123212	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419104	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR9	LOF	PL2-3	6h	1 ug/ml	B lymphocytes	AM14 TLR9 KO PL2-3 Treated - 6 hours - mAdbID:123213	Unstimulated Pooled B-cell Control	AM14 TLR9 KO PL2-3 Treated - 6 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr9-/- gene knock out	treatment: PL2-3	time: 6 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123213	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419105	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR9	LOF	PL2-3	24h	1 ug/ml	B lymphocytes	AM14 TLR9 KO PL2-3 Treated - 24 hours - mAdbID:123214	Unstimulated Pooled B-cell Control	AM14 TLR9 KO PL2-3 Treated - 24 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr9-/- gene knock out	treatment: PL2-3	time: 24 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123214	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419106	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR9	LOF	PL2-3	42h	1 ug/ml	B lymphocytes	AM14 TLR9 KO PL2-3 Treated - 42 hours - mAdbID:123215	Unstimulated Pooled B-cell Control	AM14 TLR9 KO PL2-3 Treated - 42 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr9-/- gene knock out	treatment: PL2-3	time: 42 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123215	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419107	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR7;TLR9	LOF	(Veh)	0h		B lymphocytes	AM14 TLR7 TLR9 KO Untreated - 0 hour - mAdbID:123216	Unstimulated Pooled B-cell Control	Unstimulated AM14 TLR7 TLR9 KO - 0 hour	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr7/9-/- gene knock out	treatment: Unstimulated	time: 0 hour	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123216	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419108	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR7;TLR9	LOF	PL2-3	6h	1 ug/ml	B lymphocytes	AM14 TLR7 TLR9 KO PL2-3 Treated - 6 hours - mAdbID:123217	Unstimulated Pooled B-cell Control	AM14 TLR7 TLR9 KO PL2-3 Treated - 6 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr7/9-/- gene knock out	treatment: PL2-3	time: 6 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123217	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419109	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR7;TLR9	LOF	PL2-3	24h	1 ug/ml	B lymphocytes	AM14 TLR7 TLR9 KO PL2-3 Treated - 24 hours - mAdbID:123218	Unstimulated Pooled B-cell Control	AM14 TLR7 TLR9 KO PL2-3 Treated - 24 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr7/9-/- gene knock out	treatment: PL2-3	time: 24 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123218	NA	NA	NA	NA	NA	NA	NA	NA
GSE58756	GSM1419110	2CCommonRef|TS	Cy3	"No replicates, try alternative analysis?"	1	0	1		0	TLR7;TLR9	LOF	PL2-3	42h	1 ug/ml	B lymphocytes	AM14 TLR7 TLR9 KO PL2-3 Treated - 42 hours - mAdbID:123219	Unstimulated Pooled B-cell Control	AM14 TLR7 TLR9 KO PL2-3 Treated - 42 hours	tissue: spleen	cell type: B cells	genotype/variation: gene knock out	"genotype/variation: WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-"	"other: Sample Pooling Protocol: Pool of unstimulated AM14 B cell RNAs from all genotypes (WT, Tlr7-/-, Tlr9-/- and Tlr7/9-/-)."	NA	NA	tissue: spleen	cell type: B cells	genotype/variation: Tlr7/9-/- gene knock out	treatment: PL2-3	time: 42 hours	strain: AM14	strain: AM14	GPL13912	NA	mAdb experiment ID: 123219	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE65309	GSM1592196	1C			a	0	1		1			(Veh)			Dermal Monocytes	BMN_BC1_MoGene	Monocytes.Dermis	NA	cell type: Dermal Monocytes	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChiMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592197	1C			a	0	1		1			(Veh)			Dermal Monocytes	BMN_BC2_MoGene	Monocytes.Dermis	NA	cell type: Dermal Monocytes	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChiMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592198	1C			a	0	1		1			(Veh)			Dermal Monocytes	BMN_BC4_MoGene	Monocytes.Dermis	NA	cell type: Dermal Monocytes	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChiMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592199	1C			A	0	1		0			imiquimod	5d	5%	Dermal Monocytes	BMN_FH2_MoGene	Monocytes.Dermis.IMQ.D5	NA	cell type: Dermal Monocytes	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChiMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592200	1C			A	0	1		0			imiquimod	5d	5%	Dermal Monocytes	BMN_FH3_MoGene	Monocytes.Dermis.IMQ.D5	NA	cell type: Dermal Monocytes	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChiMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592201	1C			A	0	1		0			imiquimod	5d	5%	Dermal Monocytes	BMN_FH4_MoGene	Monocytes.Dermis.IMQ.D5	NA	cell type: Dermal Monocytes	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChiMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592202	1C			a	0	1		1			(Veh)			Dermal Ly-6Chigh moDCs	BMN_BD1_MoGene	Ly6ChighmoDC.Dermis	NA	cell type: Dermal Ly-6Chigh moDCs	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChighMHCII+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592203	1C			a	0	1		1			(Veh)			Dermal Ly-6Chigh moDCs	BMN_BD2_MoGene	Ly6ChighmoDC.Dermis	NA	cell type: Dermal Ly-6Chigh moDCs	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChighMHCII+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592204	1C			a	0	1		1			(Veh)			Dermal Ly-6Chigh moDCs	BMN_BD4_MoGene	Ly6ChighmoDC.Dermis	NA	cell type: Dermal Ly-6Chigh moDCs	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChighMHCII+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592205	1C			B	0	1		0			imiquimod	5d	5%	Dermal Ly-6Chigh moDCs	BMN_FI2_MoGene	Ly6ChighmoDC.Dermis.IMQ.D5	NA	cell type: Dermal Ly-6Chigh moDCs	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChighMHCII+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592206	1C			B	0	1		0			imiquimod	5d	5%	Dermal Ly-6Chigh moDCs	BMN_FI3_MoGene	Ly6ChighmoDC.Dermis.IMQ.D5	NA	cell type: Dermal Ly-6Chigh moDCs	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChighMHCII+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592207	1C			B	0	1		0			imiquimod	5d	5%	Dermal Ly-6Chigh moDCs	BMN_FI4_MoGene	Ly6ChighmoDC.Dermis.IMQ.D5	NA	cell type: Dermal Ly-6Chigh moDCs	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChighMHCII+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592208	1C			A	0	1		0			imiquimod	11d	5%	Dermal Ly-6Chigh moDCs	BMN_GF1_MoGene	Ly6ChighmoDC.Dermis.IMQ.D11	NA	cell type: Dermal Ly-6Chigh moDCs	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChighMHCII+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592209	1C			A	0	1		0			imiquimod	11d	5%	Dermal Ly-6Chigh moDCs	BMN_GF2_MoGene	Ly6ChighmoDC.Dermis.IMQ.D11	NA	cell type: Dermal Ly-6Chigh moDCs	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChighMHCII+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592210	1C			A	0	1		0			imiquimod	11d	5%	Dermal Ly-6Chigh moDCs	BMN_GF3_MoGene	Ly6ChighmoDC.Dermis.IMQ.D11	NA	cell type: Dermal Ly-6Chigh moDCs	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64lowCCR2+Ly-6ChighMHCII+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592211	1C			a	0	1		1			(Veh)			Dermal MHCIIlow Macrophages	BMN_BG1_MoGene	MHCIIlowMF.Dermis	NA	cell type: Dermal MHCIIlow Macrophages	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592212	1C			a	0	1		1			(Veh)			Dermal MHCIIlow Macrophages	BMN_BG2_MoGene	MHCIIlowMF.Dermis	NA	cell type: Dermal MHCIIlow Macrophages	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592213	1C			a	0	1		1			(Veh)			Dermal MHCIIlow Macrophages	BMN_BG4_MoGene	MHCIIlowMF.Dermis	NA	cell type: Dermal MHCIIlow Macrophages	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592214	1C			A	0	1		0			imiquimod	5d	5%	Dermal MHCIIlow Macrophages	BMN_FQ2_MoGene	MHCIIlowMF.Dermis.IMQ.D5	NA	cell type: Dermal MHCII low Macrophages	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592215	1C			B	0	1		0			imiquimod	5d	5%	Dermal MHCIIlow Macrophages	BMN_FQ3_MoGene	MHCIIlowMF.Dermis.IMQ.D5	NA	cell type: Dermal MHCIIlow Macrophages	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592216	1C			B	0	1		0			imiquimod	5d	5%	Dermal MHCIIlow Macrophages	BMN_FQ4_MoGene	MHCIIlowMF.Dermis.IMQ.D5	NA	cell type: Dermal MHCIIlow Macrophages	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592217	1C			A	0	1		0			imiquimod	11d	5%	Dermal MHCIIlow Macrophages	BMN_GB1_MoGene	MHCIIlowMF.Dermis.IMQ.D11	NA	cell type: Dermal MHCIIlow Macrophages	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592218	1C			A	0	1		0			imiquimod	11d	5%	Dermal MHCIIlow Macrophages	BMN_GB2_MoGene	MHCIIlowMF.Dermis.IMQ.D11	NA	cell type: Dermal MHCIIlow Macrophages	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592219	1C			A	0	1		0			imiquimod	11d	5%	Dermal MHCIIlow Macrophages	BMN_GB3_MoGene	MHCIIlowMF.Dermis.IMQ.D11	NA	cell type: Dermal MHCIIlow Macrophages	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIlow	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592220	1C			a	0	1		1			(Veh)			Dermal MHCIIhi Macrophages	BMN_BF1_MoGene	MHCIIhighMF.Dermis	NA	cell type: Dermal MHCIIhi Macrophages	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIhi	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592221	1C			a	0	1		1			(Veh)			Dermal MHCIIhi Macrophages	BMN_BF2_MoGene	MHCIIhighMF.Dermis	NA	cell type: Dermal MHCIIhi Macrophages	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIhi	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592222	1C			a	0	1		1			(Veh)			Dermal MHCIIhi Macrophages	BMN_BF4_MoGene	MHCIIhighMF.Dermis	NA	cell type: Dermal MHCIIhi Macrophages	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIhi	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592223	1C			A	0	1		0			imiquimod	11d	5%	Dermal MHCIIhi Macrophages	BMN_GC1_MoGene	MHCIIhighMF.Dermis.IMQ.D11	NA	cell type: Dermal MHCIIhi Macrophages	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIhi	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592224	1C			A	0	1		0			imiquimod	11d	5%	Dermal MHCIIhi Macrophages	BMN_GC2_MoGene	MHCIIhighMF.Dermis.IMQ.D11	NA	cell type: Dermal MHCIIhi Macrophages	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIhi	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592225	1C			A	0	1		0			imiquimod	11d	5%	Dermal MHCIIhi Macrophages	BMN_GC3_MoGene	MHCIIhighMF.Dermis.IMQ.D11	NA	cell type: Dermal MHCIIhi Macrophages	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64hiCCR2lowLy-6ClowMHCIIhi	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592226	1C			a	0	1		1			(Veh)			Dermal CD11b+ conventional DCs	BMN_BH1_MoGene	CD11b+DC.Dermis	NA	cell type: Dermal CD11b+ conventional DCs	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64-Ly-6C-MHCII+ CD24-	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592227	1C			a	0	1		1			(Veh)			Dermal CD11b+ conventional DCs	BMN_BH2_MoGene	CD11b+DC.Dermis	NA	cell type: Dermal CD11b+ conventional DCs	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64-Ly-6C-MHCII+ CD24-	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592228	1C			a	0	1		1			(Veh)			Dermal CD11b+ conventional DCs	BMN_BH4_MoGene	CD11b+DC.Dermis	NA	cell type: Dermal CD11b+ conventional DCs	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64-Ly-6C-MHCII+ CD24-	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592229	1C			B	0	1		0			imiquimod	5d	5%	Dermal CD11b+ conventional DCs	BMN_FG2_MoGene	CD11b+DC.Dermis.IMQ.D5	NA	cell type: Dermal CD11b+ conventional DCs	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64-Ly-6C-MHCII+ CD24-	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592230	1C			B	0	1		0			imiquimod	5d	5%	Dermal CD11b+ conventional DCs	BMN_FG3_MoGene	CD11b+DC.Dermis.IMQ.D5	NA	cell type: Dermal CD11b+ conventional DCs	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64-Ly-6C-MHCII+ CD24-	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592231	1C			B	0	1		0			imiquimod	5d	5%	Dermal CD11b+ conventional DCs	BMN_FG4_MoGene	CD11b+DC.Dermis.IMQ.D5	NA	cell type: Dermal CD11b+ conventional DCs	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64-Ly-6C-MHCII+ CD24-	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592232	1C			A	0	1		0			imiquimod	11d	5%	Dermal CD11b+ conventional DCs	BMN_GA1_MoGene	CD11b+DC.Dermis.IMQ.D11	NA	cell type: Dermal CD11b+ conventional DCs	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64-Ly-6C-MHCII+ CD24-	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592233	1C			A	0	1		0			imiquimod	11d	5%	Dermal CD11b+ conventional DCs	BMN_GA2_MoGene	CD11b+DC.Dermis.IMQ.D11	NA	cell type: Dermal CD11b+ conventional DCs	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64-Ly-6C-MHCII+ CD24-	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592234	1C			A	0	1		0			imiquimod	11d	5%	Dermal CD11b+ conventional DCs	BMN_GA3_MoGene	CD11b+DC.Dermis.IMQ.D11	NA	cell type: Dermal CD11b+ conventional DCs	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+CD64-Ly-6C-MHCII+ CD24-	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592235	1C			a	0	1		1			(Veh)			Epidermal Langerhans Cells	BMN_FS1_MoGene	LC.Epidermis	NA	cell type: Epidermal Langerhans Cells	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+MHCII+CD24+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592236	1C			a	0	1		1			(Veh)			Epidermal Langerhans Cells	BMN_FS2_MoGene	LC.Epidermis	NA	cell type: Epidermal Langerhans Cells	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+MHCII+CD24+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592237	1C			a	0	1		1			(Veh)			Epidermal Langerhans Cells	BMN_FS3_MoGene	LC.Epidermis	NA	cell type: Epidermal Langerhans Cells	treatment: Untreated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+MHCII+CD24+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592238	1C			B	0	1		0			imiquimod	5d	5%	Epidermal Langerhans Cells	BMN_FJ2_MoGene	LC.Epidermis.IMQ.D5	NA	cell type: Epidermal Langerhans Cells	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+MHCII+CD24+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592239	1C			B	0	1		0			imiquimod	5d	5%	Epidermal Langerhans Cells	BMN_FJ3_MoGene	LC.Epidermis.IMQ.D5	NA	cell type: Epidermal Langerhans Cells	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+MHCII+CD24+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592240	1C			B	0	1		0			imiquimod	5d	5%	Epidermal Langerhans Cells	BMN_FJ4_MoGene	LC.Epidermis.IMQ.D5	NA	cell type: Epidermal Langerhans Cells	treatment: 5 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+MHCII+CD24+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592241	1C			A	0	1		0			imiquimod	11d	5%	Epidermal Langerhans Cells	BMN_GD1_MoGene	LC.Epidermis.IMQ.D11	NA	cell type: Epidermal Langerhans Cells	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+MHCII+CD24+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592242	1C			A	0	1		0			imiquimod	11d	5%	Epidermal Langerhans Cells	BMN_GD2_MoGene	LC.Epidermis.IMQ.D11	NA	cell type: Epidermal Langerhans Cells	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+MHCII+CD24+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE65309	GSM1592243	1C			A	0	1		0			imiquimod	11d	5%	Epidermal Langerhans Cells	BMN_GD3_MoGene	LC.Epidermis.IMQ.D11	NA	cell type: Epidermal Langerhans Cells	treatment: 11 days of IMQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	cell population: CD11b+MHCII+CD24+	NA	GPL6246	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE70520	GSM1808335	Htseq			A	0	1		0			R848	5d		bone marrow  macrophages	R848-1	Sorted CD11b+F4/80+ macrophages from cultured bone marrow CMP treated with SCF+R848 for 5 days	NA	treatment: R848+SCF	time: 5 days	cell population: CD11b+F4/80+ cells differentiated from CMP	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL17021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE70520	GSM1808336	Htseq			A	0	1		0			R848	5d		bone marrow  macrophages	R848-2	Sorted CD11b+F4/80+ macrophages from cultured bone marrow CMP treated with SCF+R848 for 5 days	NA	treatment: R848+SCF	time: 5 days	cell population: CD11b+F4/80+ cells differentiated from CMP	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL17021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE70520	GSM1808337	Htseq			A	0	1		0			R848	5d		bone marrow  macrophages	R848-3	Sorted CD11b+F4/80+ macrophages from cultured bone marrow CMP treated with SCF+R848 for 5 days	NA	treatment: R848+SCF	time: 5 days	cell population: CD11b+F4/80+ cells differentiated from CMP	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL17021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE70520	GSM1808338	Htseq			a	0	1		1			(Veh)	5d		bone marrow  macrophages	MCSF-1	Sorted CD11b+F4/80+ macrophages from cultured bone marrow CMP treated with SCF+MCSF for 5 days	NA	treatment: MCSF+SCF	time: 5 days	cell population: CD11b+F4/80+ cells differentiated from CMP	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL17021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE70520	GSM1808339	Htseq			a	0	1		1			(Veh)	5d		bone marrow  macrophages	MCSF-2	Sorted CD11b+F4/80+ macrophages from cultured bone marrow CMP treated with SCF+MCSF for 5 days	NA	treatment: MCSF+SCF	time: 5 days	cell population: CD11b+F4/80+ cells differentiated from CMP	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL17021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GSE70520	GSM1808340	Htseq			a	0	1		1			(Veh)	5d		bone marrow  macrophages	MCSF-3	Sorted CD11b+F4/80+ macrophages from cultured bone marrow CMP treated with SCF+MCSF for 5 days	NA	treatment: MCSF+SCF	time: 5 days	cell population: CD11b+F4/80+ cells differentiated from CMP	NA	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL17021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE98480	GSM2597248	1C			a	0	1		1			(Veh)	6d		monocytes	114_1 G4_6991001048_A	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a++CD14-	treatment: untreated	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 1	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597249	1C			C	0	1		0			R848	6d	1 ug/ml	monocytes	114_1 R848_6991001048_B	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a- CD14+	treatment: R848	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 1	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597250	1C			A	0	1		0			LPS	6d	30 ng/ml	monocytes	114_1 LPS_6991001048_C	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a-/+ CD14-/+	treatment: LPS	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 1	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597251	1C			B	0	1		0			pIC	6d	50 ug/ml	monocytes	114_1 PIC_6991001048_D	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a+ CD14-/+	treatment: PIC	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 1	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597252	1C			a	0	1		1			(Veh)	6d		monocytes	114_4 G4_6991001048_E	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a++CD14-	treatment: untreated	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 2	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597253	1C			C	0	1		0			R848	6d	1 ug/ml	monocytes	114_4 R848_6991001048_F	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a- CD14+	treatment: R848	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 2	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597254	1C			A	0	1		0			LPS	6d	30 ng/ml	monocytes	114_4 LPS_6991001048_G	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a-/+ CD14-/+	treatment: LPS	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 2	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597255	1C			B	0	1		0			pIC	6d	50 ug/ml	monocytes	114_4 PIC_6991001048_H	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a+ CD14-/+	treatment: PIC	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 2	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597256	1C			a	0	1		1			(Veh)	6d		monocytes	114_5 G4_6991001048_I	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a++CD14-	treatment: untreated	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 3	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597257	1C			C	0	1		0			R848	6d	1 ug/ml	monocytes	114_5 R848_6991001048_J	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a- CD14+	treatment: R848	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 3	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597258	1C			A	0	1		0			LPS	6d	30 ng/ml	monocytes	114_5 LPS_6991001048_K	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a-/+ CD14-/+	treatment: LPS	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 3	NA	NA	NA	NA	NA	NA	NA	NA
GSE98480	GSM2597259	1C			B	0	1		0			pIC	6d	50 ug/ml	monocytes	114_5 PIC_6991001048_L	human blood monocytes	NA	isolated cell-type: CD14+ monocytes	age of cells in culture: 6 days	phenotype: CD1a+ CD14-/+	treatment: PIC	NA	NA	NA	NA	NA	NA	NA	NA	tissue: blood	NA	GPL10558	NA	replicate 3	NA	NA	NA	NA	NA	NA	NA	NA
						NA			NA																																		
GSE25677	GSM630822	1C			A	0	1		0			MPL	7d	5 mg/ml	B lymphocytes	B cells from mice treated with MPL - rep 1	MPL-treated_1	NA	cell type: B-cell	stimulation: MPL (TLR4 ligand)	time: 7 days post-treatment	cell markers: TCRbeta-CD11b-CD19+IgD-IgG+ B cells	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Gene expression from FACS-sorted B cells	NA	NA	NA	NA	NA	NA	NA	NA
GSE25677	GSM630823	1C			C	0	1		0			R837	7d	10-20 mg/ml	B lymphocytes	B cells from mice treated with R837 - rep 1	R837-treated_1	NA	cell type: B-cell	stimulation: R837 (TLR7 ligand)	time: 7 days post-treatment	cell markers: TCRbeta-CD11b-CD19+IgD-IgG+ B cells	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Gene expression from FACS-sorted B cells	NA	NA	NA	NA	NA	NA	NA	NA
GSE25677	GSM630824	1C			B	0	1		0			MPL;R837	7d	5 mg/ml;10-20 mg/ml	B lymphocytes	B cells from mice treated with MPL and R837 - rep 1	MPL and R837-treated_1	NA	cell type: B-cell	stimulation: MPL (TLR4 ligand) + R837 (TLR7 ligand)	time: 7 days post-treatment	cell markers: TCRbeta-CD11b-CD19+IgD-IgG+ B cells	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Gene expression from FACS-sorted B cells	NA	NA	NA	NA	NA	NA	NA	NA
GSE25677	GSM630825	1C			A	0	1		0			MPL	7d	5 mg/ml	B lymphocytes	B cells from mice treated with MPL - rep 2	MPL-treated_2	NA	cell type: B-cell	stimulation: MPL (TLR4 ligand)	time: 7 days post-treatment	cell markers: TCRbeta-CD11b-CD19+IgD-IgG+ B cells	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Gene expression from FACS-sorted B cells	NA	NA	NA	NA	NA	NA	NA	NA
GSE25677	GSM630826	1C			C	0	1		0			R837	7d	10-20 mg/ml	B lymphocytes	B cells from mice treated with R837 - rep 2	R837-treated_2	NA	cell type: B-cell	stimulation: R837 (TLR7 ligand)	time: 7 days post-treatment	cell markers: TCRbeta-CD11b-CD19+IgD-IgG+ B cells	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Gene expression from FACS-sorted B cells	NA	NA	NA	NA	NA	NA	NA	NA
GSE25677	GSM630827	1C			B	0	1		0			MPL;R837	7d	5 mg/ml;10-20 mg/ml	B lymphocytes	B cells from mice treated with MPL and R837 - rep 2	MPL and R837-treated_2	NA	cell type: B-cell	stimulation: MPL (TLR4 ligand) + R837 (TLR7 ligand)	time: 7 days post-treatment	cell markers: TCRbeta-CD11b-CD19+IgD-IgG+ B cells	NA	NA	NA	NA	NA	NA	NA	NA	strain: C57BL/6	NA	GPL6246	NA	Gene expression from FACS-sorted B cells	NA	NA	NA	NA	NA	NA	NA	NA
